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Abstract 
 
 
 The primary objective of the study was to assess the psychometric properties of a 
hypertension knowledge instrument in a vulnerable population.  The secondary objective 
was to determine the association between hypertension knowledge and outcomes such as 
systolic and diastolic blood pressure and hemoglobin A1c. 
 
A cross-sectional study was conducted using a convenience sample of 196 adults aged 18 
years and older with hypertension.  Item analysis was conducted to determine the 
reliability of the instrument.  The factor structure was determined and confirmed using 
exploratory factor analysis and confirmatory factor analysis, respectively.  Logistic 
regression analysis was used to determine the associated between hypertension 
knowledge and hypertension-related outcomes. 
 
The Cronbach’s alpha for the original hypertension knowledge instrument was 0.597.  
Using results from the item analysis and the exploratory factor analysis, the refined 
instrument produced a Cronbach’s alpha of 0.598.  A three-factor solution was confirmed 
by the confirmatory factor analysis.  Hypertension knowledge was not significantly 
associated with any hypertension-related outcome. 
 
The hypertension knowledge instrument exhibits acceptable psychometric properties.  
More research needs to be done to confirm the psychometric properties of the instrument 
and to elucidate the relationship between hypertension knowledge and outcomes. 
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Chapter 1. Introduction 
 
 
Background 
 
Hypertension, which is defined as a systolic blood pressure greater than or equal to 140 
mmHg and a diastolic blood pressure blood pressure greater than or equal to 90 mmHg or 
taking medication to control hypertension, affected approximately 29% of Americans 
aged 18 years and older in 2005–2006.1  A cardiovascular disease in and of itself, 
hypertension not only puts people at an increased risk for other cardiovascular diseases 
but also for stroke and renal disease.  Interestingly, in 2003–2004, 75% of patients who 
reported having diabetes also reported having hypertension.2  Hypertension and diabetes 
are responsible for a large percentage of the morbidity and mortality in the United States.  
In 2006, heart disease, diabetes, and hypertension were the first, sixth, and thirteenth 
leading causes of death in the United States.3  
 
Studies have shown that small reductions in blood pressure can lead to significant 
reductions in microvascular and macrovascular complications.4  Because a large majority 
of patients with diabetes also have hypertension, efforts have recently turned towards 
reducing diabetes-related complications by controlling the blood pressure of patients with 
diabetes.  The Systolic Hypertension in the Elderly Program (SHEP), the Hypertension 
Detection and Follow-up Program (HDFP), and the Systolic Hypertension in Europe 
(Syst-Eur) studies all involve the reduction of blood pressure in patients with diabetes in 
an attempt to lower the risk for cardiovascular complications.  These studies all found 
significant reduction in the risk for cardiovascular complications and mortality by 
intensively treating diabetic patients’ blood pressure.5  Other studies have shown that 
successfully managing hypertension, especially with angiotensin-converting enzyme 
inhibitors, results in improved renal and retinal outcomes.6-10 
 
 
Description of the Problem 
 
 As the age-adjusted prevalence of hypertension in non-institutionalized people aged 20 
years and older increased from 25.5% in 1988–1994 to 31.3% in 2003–2006, health care 
providers have focused their attention on not only drug therapy management of 
hypertension but also on educational interventions that increase patients’ knowledge of 
the necessary self-care behaviors and risks associated with uncontrolled hypertension.11,12  
This increase in educational interventions aimed at increasing patient disease state and 
self-care knowledge has led to the need for instruments that assess whether patients are 
actually acquiring the intended knowledge.  Currently, in the literature there are 
numerous instruments used to assess patients’ knowledge about their hypertension.  
These instruments vary in the soundness of their psychometric properties and in their 
actual content and design.13-19  The formats of the available instruments range from a 
true/false format to Likert-type responses, which appear to measure outcome 
expectancies and not actual knowledge.  Interestingly, none of the hypertension 
knowledge instruments available utilize a multiple-choice format as this study proposed 
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to do.  By developing a psychometrically sound instrument that assessed hypertensive 
patients’ knowledge base, the study will make it possible to quantitatively determine if 
the patient has acquired the knowledge necessary to meet their hypertensive health care 
demands. 
 
 
Theoretical Framework 
 
 The theoretical framework for the study was adapted with permission from the Integrated 
Theory of Health Behavior Change (ITHBC) (Appendix A).  Although ITHBC is a new 
theory, having first been reported in the literature in 2009, it is a descriptive mid-range 
theory that seeks to identify and describe the factors that explain health behavior 
change.20  The ITHBC was developed from components of interventions in the literature 
that produced behavior change in the populations being studied.  Additionally, the theory 
incorporates other theories that address health behavior change, social support, and self-
management of chronic disease states in order to more completely describe the dynamic 
process of health behavior change.20 
 
Before one can really understand the constructs and relationships of the ITHBC, one must 
have knowledge of the assumptions on which the theory is based.  The ITHBC is based 
on the following assumptions:20 
 
Behavior change is a dynamic iterative process.  Desire and motivation are 
prerequisites to change, and self-reflection facilitates progress.  Positive social 
influences sway one’s interest and willingness just as positive relationships help 
to support and sustain change.  Engagement in healthy behavior is an outcome 
that can be realized in the short term (a proximal outcome), and engagement in 
health behavior influences and leads to improvement in health status, the distal 
outcome (Ryan 2009, p. 164). 
 
The ITHBC is composed of three major constructs that come together to fully explain 
health behavior change: knowledge and beliefs, self-regulation skill and ability, and 
social facilitation.20  According to the ITHBC, no one construct by itself can cause 
behavior change.  Instead, it is the relationships between the constructs that exact 
change.20  Figure 1.1 illustrates the relationship between an individual’s knowledge and 
beliefs, self-regulation skill and ability, and social facilitation, which in turn result in the 
engagement in self-management behavior and the improvement in health status.20  As can 
be seen in Figure 1.1, increased knowledge and positive social influence leads an 
engagement in self-care skill and ability.  This engagement in self-regulation skill and 
ability leads to the engagement in self-management behaviors, when then causes and 
improvement status.20 
 
 Because the current study sought to examine the relationship between condition-specific 
(hypertension) knowledge and health status, the ITHBC was adapted as the theoretical 
framework for the study.  The advantage that the ITHBC has over other health behavior 
change theories is that it explicitly takes into account disease state knowledge as well as 
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Figure 1.1.  Integrated Theory of Health Behavior Change 
 
Reprinted with permission from Lippincott Williams & Wilkins.  Ryan P. Integrated 
Theory of Health Behavior Change: Background and intervention development. Clin 
Nurse Spec 2009;23:161–170. 
 
 4 
other constructs such as social facilitation.  Figure 1.2 depicts the adaption of the ITHBC 
for the knowledge instrument that was used in this study to measure hypertension 
knowledge and to examine its relationship with health status.   
 
Based on Figure 1.2, the theoretical framework for the study proposed that higher scores 
on the hypertension knowledge instrument would enhance self-regulation skill and 
ability.  Additionally, social facilitators such as being married, higher level of educational 
attainment, insurance status, higher functional health literacy, as measured by the short 
form Test of Functional Health Literacy in Adults (S-TOFHLA), would also enhance 
self-regulation skill and ability.  Self-regulation skill and ability would then result in the 
engagement of self-management behavior.  The variable number of hypertension-related 
complications was included as a representation of the engagement in self-care behavior 
because as the number of complications increases, the number of self-care behaviors that 
an individual must engage in also increases.  Therefore, it was believed that this increase 
in the number of disease-specific self-care behaviors would take focus away from 
hypertension self-care behaviors and result in decreased health status with respect to 
hypertension.  The engagement in self-management behavior would result in improved 
health status as evident by blood pressure at goal, a serum creatinine (Scr) within normal 
limits, and a hemoglobin A1c (HbA1c) at goal.  
 
 
Purpose of the Study 
 
 The primary purpose of the study was to describe the development and validation of an 
instrument that assessed the knowledge required of patients with hypertension to 
effectively manage their blood pressure.  The secondary purpose of the study was to 
determine the association between hypertension knowledge and outcomes such as 
systolic and diastolic blood pressure and HbA1c.  Other outcomes investigated are known 
complications of hypertension: history of congestive heart failure, stroke, myocardial 
infarction, peripheral vascular disease, elevated Scr, and end stage renal disease (ESRD). 
 
 
Study Objectives and Research Questions 
 
 The study objectives and their respective research questions were: 
 
1. Create an instrument and assess the psychometric properties of the hypertension 
knowledge instrument. 
a.  What is the factor structure make-up of the instrument? 
b.  Does the instrument exhibit acceptable reliability with respect to internal 
consistency? 
2. Assess whether scores on the hypertension knowledge instrument are associated 
with hypertension-related outcomes. 
a. How do scores on the hypertension knowledge instrument correlate with 
systolic blood pressure control? 
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Figure 1.2.  Conceptual framework of Integrated Theory of Health Behavior 
Change 
 
Note:  Words in italics are variables to be measured. 
Modified with permission from Lippincott Williams & Wilkins.  Ryan P. Integrated 
Theory of Health Behavior Change: Background and intervention development. Clin 
Nurse Spec 2009;23:161–170. 
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b. How do scores on the hypertension knowledge instrument correlate with 
total blood pressure control? 
c. How do scores on the hypertension knowledge instrument correlate with 
having a serum creatinine within normal limits? 
d. How do scores on the hypertension knowledge instrument correlate with 
having a hemoglobin A1c at goal? 
 
 
Definitions of Terms and Concepts 
 
Beliefs: Beliefs refer to how a person feels about a disease state or a necessary health 
behavior.20 
 
Diabetes mellitus: Diabetes mellitus is defined as a fasting plasma glucose of greater than 
or equal to 126 mg/dL or a 2-hour plasma glucose level greater than or equal to 200 
mg/dL.21 
 
Functional health literacy: Functional health literacy is context specific and is the ability 
to read and comprehend healthcare-related materials.22 
 
Goal congruence: Goal congruence refers to the process that an individual goes through 
in order to satisfy the demands necessary to achieve their health goals.20 
 
Hemoglobin A1c: Hemoglobin A1c, HbA1c, is the amount of glycolated hemoglobin in 
an individual’s blood.  Hemoglobin A1c is often used as a measure of glucose control 
over the past 3 months.  For individuals without diabetes, HbA1c is normally less than 
6%.  For individuals with diabetes, a HbA1c goal of less than 7% is desired.23  
 
Hypertension: Hypertension is defined as a systolic blood pressure greater than or equal 
to 140 mmHg and a diastolic blood pressure greater than or equal to 90 mmHg or having 
a diagnosis by a health care provider of hypertension.24 
 
Hypertension knowledge: Hypertension knowledge is the factual information regarding 
the complications, medication therapy, and self-care behavior necessary for effective 
management of hypertension.20 
 
Knowledge: Knowledge is factual information.20 
 
Macrovascular complications: Macrovascular complications are complications of the 
large vessels in the body and include coronary artery disease, peripheral arterial disease, 
and stroke.25 
 
Microvascular complications: Microvascular complications are complications of the 
small vessels in the body and include nephropathy, neuropathy, and retinopathy.25 
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Outcome expectancy: Outcome expectancy is the belief that a certain behavior will yield 
a particular outcome.20 
 
Predictive Analytic Software (PASW®): PASW®  is a statistical software package 
(Version 18, IBM Corporation, Somers, NY) used to analyze the data.26 
 
Psychometrics: Psychometrics is a psychological field of study concerned with the theory 
and technique of test measurment.27 
 
Reliability: Reliability is the ability of an instrument to measure the intended underlying 
dimensions.28 
 
SAS®: SAS® is a statistical package. The confirmatory factor analysis was generated 
using SAS software, Version 9.1.3 of the SAS System for Windows XP. Copyright © 
2007 SAS Institute Inc.  SAS and all other SAS Institute Inc. product or service names 
are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.29 
 
Self-care behaviors: Self-care behaviors are the condition-specific behaviors that 
individuals must engage in to effectively and successfully manage their condition. 
 
Self-efficacy: Self-efficacy is the confidence that one can change their situation.20 
 
Self-regulation: Self-regulation is the process that individuals must go through in order to 
successfully incorporate new behaviors into their lifestyles.20 
 
Social facilitation: Social facilitation is the positive influence derived from the support of 
an individual’s community, family, and healthcare providers that aids in the engagement 
of self-care behaviors.20 
 
Social influence: Social influence refers to the ability to convince an individual to behave 
in a certain manner.20 
 
Social support: Social support is the support necessary to successfully engage in self-care 
behaviors.20 
 
Test of Functional Health Literacy in Adults (TOFHLA): The Test of Functional Health 
Literacy in Adults is a validated and accepted measure of health literacy.30 
 
 
Assumptions 
 
The assumptions of the study included the following: 
 
1.    The respondents of the instrument responded to the best of their knowledge. 
2.    Each respondent completed the instrument only once. 
3.    The study sample was representative of the target population. 
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Limitations 
 
The limitations of the study included the following: 
 
1. The study utilized a convenience sampling technique.  Therefore, the results of 
the study were not generalizable to the general population. 
2. Study participants were asked to recall their past medical histories and therefore 
recall bias was potentially a problem. 
 
 
Relevance to Health Outcomes and Policy Research 
 
 As evident in the literature, there is currently a lack of psychometrically sound 
instruments that assess knowledge about complications of hypertension, symptoms, and 
self-care behaviors necessary to successfully manage hypertension.  These tools tend to 
measure outcome expectancies rather than knowledge and many of them have not had 
their psychometric properties assessed adequately.14-16,18  Additionally, some of the 
existing instruments utilize a true/false response format and thus the participant has a 
high probability of guessing correctly.19,31,32  Therefore, the results of this study will fill a 
gap in the literature. 
 
 Additionally, it is hoped that the instrument will be clinically useful.  As health care 
providers continue to work to improve patient outcomes with respect to hypertension, the 
instrument will provide a visual method to express to patients the relationship between 
their knowledge and their potential for hypertension-related outcomes.  Finally, the 
instrument will provide health care providers with helpful information regarding which 
areas of hypertension the patient needs to continue to address.  
 
 
Organization of the Dissertation 
 
The dissertation is organized into five chapters.  Chapter 1, the introductory chapter, 
provides the rationale and relevance for the study.  Chapter 2 provides an in-depth review 
of the literature in which the relationship between blood pressure control and diabetes 
outcomes is discussed.  The recommendations for the effective self-care management of 
hypertension in addition to the current hypertension knowledge tools are also reviewed in 
Chapter 2.  Chapter 3 covers the methodology of the study while Chapter 4 provides the 
results of the study analyses.  Finally, Chapter 5 not only discusses the results and 
conclusions of the study but also provides a discussion of the study’s limitations and 
recommendations for future research.   
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Chapter 2. Literature Review 
 
 
Hypertension is associated with extensive morbidity and mortality and costs billions of 
dollars each year to manage and treat, thereby placing a substantial burden on society.  In 
order to fully understand the drug therapy and lifestyle activities that are essential to the 
successful treatment and management of hypertension, the Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC-7) guideline is presented.  Because the study site serves mainly minority 
patients, the disparity in hypertension control between blacks and white is also examined.  
Finally, the relationship between health literacy and health outcomes and hypertension 
knowledge and hypertension outcomes are discussed in order to present why disease state 
knowledge and literacy are important in and necessary to achieve clinical goals. 
 
 
Cost and Prevalence of Hypertension  
 
In 2001, uncontrolled blood pressure globally cost $370 billion.33  For the same year, the 
United States’ incremental annual direct cost for patients with hypertension was $54 
billion dollars, after controlling for demographics and co-morbidities.  The United States’ 
mean incremental annual per capital direct cost for a hypertensive patient was $1,131.  
Prescription medications and inpatient and outpatient visits were responsible for more 
than 90% of the overall incremental cost of treating hypertension.34 
 
From 2003–2006, the age-adjusted prevalence of hypertension in adults aged 20 years 
and older was 31.3% of the population.  The prevalence of hypertension in non-Hispanic 
white males was 31.2%.  Additionally, 28.3% of non-Hispanic white females had either 
elevated blood pressure and/or were taking antihypertensive medications.  Among non-
Hispanic black males and females, 42.2% and 44.1% , respectively, had hypertension 
during this time period.35  The 2003–2006 prevalence rates for both non-Hispanic whites 
and non-Hispanic blacks were increases from previous years, with the 1999–2002 
prevalence rates for non-Hispanic white males and females being 27.6% and 28.5%, 
respectively, and the rates for non-Hispanic black males and females being 40.6% and 
43.5%, respectively.35  
 
 
Treatment Guidelines for Hypertension 
 
 The current hypertension treatment guidelines, Seventh Report of the Joint National 
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 
(JNC-7), were published in 2003.24  The JNC-7 guidelines classify blood pressure into 
four categories: normal, prehypertension, stage 1 hypertension, and stage 2 hypertension.  
Table 2.1 outlines the systolic (SBP) and diastolic (DBP) blood pressures that fall within 
each category.24 
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Table 2.1.  Classification of blood pressure for adults 
 
BP Classification SBP mm Hg DBP mm Hg 
Normal < 120 and < 80 
Prehypertension 120–139 or 80–89 
Stage 1 hypertension 140–159 or 90–99 
Stage 2 hypertension ≥ 160 or ≥ 100 
 
Reprinted with permission from Lippincott Williams & Wilkins.  Chobanian AV, Bakris 
GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 
2003;42:1206–1252. 
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JNC-7 guidelines recommend that individuals with normal hypertension have their blood 
pressure rechecked in two years.  Individuals with prehypertension should be rechecked 
in one year and also be provided with information regarding lifestyle modifications. 
Patients with stage 1 hypertension should have their diagnosis confirmed and begin drug 
therapy within two months and also be instructed in the appropriate lifestyle 
modifications to manage their blood pressure.  Finally, those with stage 2 hypertension 
should be treated with drug therapy within one month of diagnosis.  As recommended for 
those who are classified as having prehypertension and stage 1 hypertension, individuals 
with stage 2 hypertension should be given advice about lifestyle modifications in 
conjunction with beginning medication therapy.24  The lifestyle modifications and the 
reductions in SBP associated with adopting the respective lifestyle modification are listed 
in Table 2.2.24 
 
The medications used in the treatment of hypertension include diuretics (thiazides, loop, 
potassium-sparing, and aldosterone receptor blockers); beta blockers, BBs; angiotensin-
converting enzyme inhibitors, ACEIs; angiotensin receptor blockers, ARBs; calcium 
channel blockers, CCBs; alpha-1 blockers; alpha-2 agonists; and direct vasodilators.  
Currently, thiazide diuretics are recommended as first-line therapy with the addition of a 
different class of hypertensive medication if an individual is not controlled on a thiazide.  
The algorithm for the treatment of hypertension recommended by the JNC-7 guidelines is 
illustrated in Figure 2.1.  Table 2.3 lists the treatment recommendations for patients with 
compelling indications in conjunction with hypertension. 
 
 
Disparities in Hypertension Control 
 
 Although, the raw 2005–2006 National Health and Nutritional Examination Survey 
(NHANES) data indicated no disparities in hypertension control among individuals who 
had hypertension and being treated, previous years’ data indicate a significant disparity 
between non-Hispanic white and black hypertensive patients being treated with 
antihypertensive medications.1  Hertz et al, using the NHANES 1999–2002 data, found a 
significant difference in the control of blood pressure among non-Hispanic whites 
(59.7%) and whites (48.9%) being treated for their hypertension.  After adjusting for 
insurance status, gender, age, socioeconomic status, weight, and behavioral 
modifications, non-Hispanic blacks were approximately twice as likely as non-Hispanic 
whites to not reach their blood pressure goal.36  Giles et al found that treated Mexican 
Americans were 29% less likely to achieve blood pressure control compared to non-
Hispanic whites.  Additionally, treated non-Hispanic blacks were 41% less likely to 
achieve blood pressure control compared to their non-Hispanic white counterparts.37  
Fiscella et al determined that if in the hypertensive population the mean SBP of blacks 
were reduced to the mean SBP of whites, then the annual number of deaths in the black 
population due to cardiovascular disease would be reduced by 5,480 and from stroke by 
2,190.38  Unfortunately, definitive causal pathways or factors have not been identified. 
 
Studies have sought to understand the differences in blood pressure control between 
blacks and whites.11,39,40  Bosworth et al investigated the potential explanatory factors 
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Table 2.2.  Lifestyle modifications to prevent and manage hypertension 
 
Modification Recommendation Approximate SBP 
Reduction (Range) 
Weight reduction Maintain normal body 
weight (body mass index 
18.5–24.9 kg/m3) 
5–10 mm Hg/10kg 
Adopt dietary approaches to 
stop hypertension (DASH) 
eating plan 
Consume a diet rich in 
fruits, vegetables, and low-
fat dairy products with a 
reduced content of saturated 
and total fat 
8–14 mm Hg 
Dietary sodium reduction Reduce dietary sodium 
intake to no more than 100 
mmol per day (2.4 g sodium 
or 6 g sodium chloride) 
2–8 mm Hg 
Physical activity Engage in regular aerobic 
physical activity such as 
brisk walking (at least 30 
minutes per day, most days 
of the week) 
4–9 mm Hg 
Moderation of alcohol 
consumption 
Limit consumption to no 
more than 2 drinks (i.e., 24 
oz beer, 10 oz wine, or 3 oz 
80-proof whiskey) per day 
in most men and to no more 
than 1 drink per day in 
women and lighter-weight 
persons 
2–4 mm Hg 
 
Reprinted with permission from Lippincott Williams & Wilkins.  Chobanian AV, Bakris 
GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 
2003;42:1206–1252.
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Figure 2.1.  Algorithm for treatment of hypertension 
 
Reprinted with permission from Lippincott Williams & Wilkins.  Chobanian AV, Bakris 
GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 
2003;42:1206–1252. 
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Table 2.3.   Clinical trial and clinical guideline basis for compelling indications for 
individual drug classes  
 
 Recommended Drugs 
Compelling Indication Diuretic BB ACEI ARB CCB Aldo ANT 
Heart failure • • • •  • 
Post-myocardial infarction  • •   • 
High coronary disease risk • • •  •  
Diabetes • • • • •  
Chronic kidney disease   • •   
Recurrent stroke prevention •  •    
 
Notes:  BB indicates β-blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB. 
Angiotensin receptor blocker; CCB, calcium channel blocker; Aldo ANT, aldosterone 
antagonist.  Compelling indications for antihypertensive drugs are based on benefits from 
outcome studies or existing clinical guidelines; the compelling indication is managed in 
parallel with the blood pressure. 
Reprinted with permission from Lippincott Williams & Wilkins.  Chobanian AV, Bakris 
GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 
2003;42:1206–1252. 
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for the racial differences in blood pressure control in two different studies.11,39  The first 
study, conducted in a Veterans Affairs hospital where disparities in access to care would 
not be a contributory factor, found that blacks were more likely to be nonadherent to 
medications, more functionally illiterate, have a family member with hypertension, 
perceive hypertension as serious and to experience increased urination compared to 
whites.  Once these factors were controlled for in the model, the odds of African 
Americans having adequate blood pressure control compared to whites decreased to 1.59 
(95% CI 1.09–2.29) from 1.70 (95% CI 1.20–2.41).39  In 2008, Bosworth et al conducted 
a follow-up study to the 2006 study.  This study also sought to determine the explanatory 
factors responsible for the differences seen in blood pressure control between blacks and 
whites.11  In adjusted analyses where the investigators sought to identify factors that 
modified the relationship between race and blood pressure by greater than 10%, worries 
about hypertension, medication nonadherence, and age were the only significant factors 
remaining in the model.11  Kressin et al found similar results in a study that investigated 
the racial disparities in blood pressure control.40  Kressin et al found that blacks were 
more likely to report worse medication adherence, more discrimination, and more 
concerns about high blood pressure and blood pressure medication.  However, once these 
factors were controlled for in the model, the investigators found that there was no longer 
a black-white disparity in blood pressure control.11   
 
 
Relationship of Hypertension Control and Diabetes Complications 
 
 Achieving optimal systolic and diastolic blood pressures has been shown to decrease the 
risk for cardiovascular disease and microvascular and macrovascular complications.  
However, there is still some controversy as to whether intensive lowering of blood 
pressure in patients with type 2 diabetes results in a significant reduction in the incidence 
and progression of diabetes-related complications.  The following six studies, also 
summarized in Table 2.4, all attempted to elucidate the relationship between intensive 
blood pressure lowering and the risk of complications in patients with type 2 diabetes. 
  
 
Systolic Hypertension in the Elderly Program (SHEP) 
 
 The SHEP trial was a multicenter, double-blind, placebo-controlled trial conducted in 
adults 60 years and older with isolated systolic hypertension.41  For the SHEP trial, 
isolated systolic hypertension was defined as a SBP greater than or equal to 160 mm Hg 
and a DBP less than 90 mm Hg.  One of the subgroup analyses conducted from the SHEP 
study data involved the examination of the effect of a diuretic-based antihypertensive 
treatment regimen on cardiovascular risk in older patients with diabetes and isolated 
systolic hypertension compared to their counterparts who only had isolated systolic 
hypertension at baseline.41  The main outcomes for the subgroup analysis were 5-year 
rates of cardiovascular disease events, nonfatal and fatal stroke, nonfatal myocardial 
infarction and fatal myocardial infarction, and all-cause mortality.  Davis et al found that 
treatment with a diuretic-based antihypertensive regimen significantly reduced 5-year 
rates of cardiovascular disease events by 34% in individuals with and without diabetes.   
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Table 2.4.  Studies addressing relationship between hypertension control and diabetes complications 
 
Study Objective Sampling Study 
Design 
Major Findings 
Systolic 
Hypertension 
in the Elderly 
Program 
(SHEP)41 
To assess the effect of 
diuretic-based 
antihypertensive 
treatment regimen on 
cardiovascular risk in 
older patients with 
diabetes and isolated 
systolic hypertension 
Men and women 
aged 60 years and 
older with a SBP ≥ 
160 mm Hg and a 
DBP < 90 mm Hg 
n = 4,736 
Multi-
center, 
double-
blind 
placebo-
controlled  
Treatment with a diuretic-based 
antihypertensive regimen 
significantly reduced 5-year rates of 
nonfatal myocardial infarction and 
fatal coronary heart disease and 
major coronary heart disease by 54% 
and 34%, respectively.  Five-year all-
cause mortality was reduced by 26% 
in participants with diabetes. 
 
UK 
Prospective 
Diabetes Study 
(UKPDS)42 
To examine the effect of 
tight blood pressure 
control on morbidity 
and mortality in patients 
with type 2 diabetes and 
hypertension 
 
Hypertensive 
patients with type 
2 diabetes 
n = 1,148 
Randomized 
controlled 
trial 
Tight blood pressure control was 
associated with a 56% reduction in 
risk for heart failure compared to less 
tight blood pressure control. 
Hypertension 
Optimal 
Treatment 
Trial (HOT)43 
To investigate the 
association between 
cardiovascular events 
and diastolic blood 
pressures 
Adults aged 50 to 
80 years of age 
with hypertension 
and diastolic blood 
pressure between 
100 mm Hg and 
115 mm Hg 
n = 28,189 
Randomized 
controlled 
trial 
Intensive blood pressure lowering to 
diastolic blood pressure less than 80 
mm Hg was associated with a two-
fold reduction in risk for all major 
cardiovascular events compared 
diastolic blood pressure lowering to 
90 mm Hg. 
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Table 2.4.  (continued) 
 
Study Objective Sampling Study 
Design 
Major Findings 
Systolic 
Hypertension 
in Europe Trial 
(Syst-Eur)44 
To determine if 
nitrendipine had 
different effects on 
long-term complications 
in diabetic and non-
diabetic individuals with 
hypertension 
 
Adults aged 60 
years and older 
with SBP between 
160 and 219 mm 
Hg and DBP < 95 
mm Hg 
n = 4,695 
 
Post hoc 
analysis 
In the diabetic group, treatment with 
nitrendipine was associated with 
significant reductions in overall 
mortality, mortality from 
cardiovascular causes, cardiovascular 
events, stroke, and cardiac events. 
Action in 
Diabetes and 
Vascular 
Disease: 
Preterax and 
Diamicron MR 
Controlled 
Evaluation 
(ADVANCE)8 
To examine the effect of 
a fixed combination of 
perindopril and 
indapamide on 
macrovascular and 
microvascular outcomes 
in patients with type 2 
diabetes, irrespective of 
initial blood pressure 
level 
 
Adults with a 
diagnosis of type 2 
diabetes at age 30 
years or older and 
age 55 years or 
older at study 
enrollment  
n = 11,140  
Randomized 
controlled 
trial 
Significantly fewer major 
macrovascular or major 
microvascular events occurred during 
study follow-up for patients receiving 
active treatment.  Active treatment 
was also associated with a significant 
21% reduction in total renal events 
and the development of 
microalbuminuria. 
ADVANCE: 
Retinal 
Measurements 
Study 
(AdRem)45 
 
To examine the blood 
pressure lowering on the 
progression of 
retinopathy in patients 
with type 2 diabetes 
Adults with a 
diagnosis of type 2 
diabetes at age 30 
years or older and 
age 55 years or 
older at study 
enrollment 
Post hoc 
analysis 
Active blood pressure lowering with 
perindopril and indapamide was 
associated with a significant 50% 
reduction in macular edema and a 
40% reduction arteriovenus nicking 
compared to placebo. 
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Additionally, the rates of nonfatal myocardial infarction and fatal coronary heart disease 
and major coronary heart disease were significantly reduced in individuals with diabetes 
by 54% and 44%, respectively.  Five-year all-cause mortality was reduced by 26% in 
participants with diabetes.  However, this reduction was not statistically significant. 
 
 
UK Prospective Diabetes Study (UKPDS) 
 
 The hypertension in diabetes study was a randomized control trial that was embedded in 
the UKPDS.42  The hypertension in diabetes study sought to examine the effect of tight 
blood pressure control, defined as a blood pressure < 150/85 mm Hg, on morbidity and 
mortality in 1148 participants with type 2 diabetes and hypertension.  The UKPDS group 
found a 56% reduction in risk in heart failure for those randomized to the tight control 
group compared to those randomized to the less tight blood pressure control group.  Tight 
control was also associated with 24%, 32%, and 37% reductions in risk in diabetes 
related endpoints, deaths due to diabetes, and microvascular complications, respectively.  
The UKPDS group also found that at nine years of follow-up, individuals in the tight 
blood pressure control group experienced a 34% reduction in risk in the proportion of 
individuals’ retinopathy progressing by greater than two steps.  Finally tight blood 
pressure control was significantly associated with a 47% reduction in the proportion of 
individuals’ deterioration in vision.  The hypertension in diabetes study did not find a 
significant reduction in risk for all-cause mortality.42 
 
 
Hypertension Optimal Treatment Trial (HOT) 
 
 The HOT trial was a randomized control trial that investigated the association between 
cardiovascular events and diastolic blood pressures.  Additionally the study sought to 
assess the relationship between diastolic blood pressure and various cardiovascular 
outcome measures.43  The HOT trial was conducted in adults aged 50 to 80 years of age 
with hypertension and a diastolic blood pressure between 100 mm Hg and 115 mm Hg.  
Participants were then randomized to three target blood pressure levels: less than or equal 
to 90 mm Hg, less than or equal to 85 mm Hg, less than or equal to 80 mm Hg.43  The 
HOT study group categorized major cardiovascular events as all myocardial infarctions, 
all strokes, and all other cardiovascular events.43  Hansson et al found that intensive 
blood-pressure lowering to diastolic blood pressure less than 80 mm Hg was associated 
with a two-fold reduction in risk for all major cardiovascular events compared to 
individuals randomized to diastolic blood pressure less than 90 mm Hg.  The diastolic 
blood pressure found to be associated with the greatest reduction cardiovascular events 
was 82.6 mm Hg.43 
 
 
Systolic Hypertension in Europe Trial (Syst-Eur) 
 
 The investigators of the Syst-Eur trial conducted a post-hoc analysis of the Syst-Eur data 
that sought to determine if nitrendipine, a dihydropyridine calcium channel blocker, had 
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different effects on long-term complications in diabetic and non-diabetic individuals with 
hypertension.44  The outcomes examined in this post-hoc analysis were overall mortality, 
mortality from cardiovascular causes, cardiovascular events, stroke, and cardiac events.  
In the diabetic group, treatment with nitrendipine was associated with significant 
reductions in overall morality (55%), mortality from cardiovascular causes (76%), 
cardiovascular events (69%), stroke (73%), and cardiac events (67%).  In non-diabetic 
patients significant reductions were only seen in cardiovascular events (26%) and stroke 
(38%).  Reductions in events were significantly greater in the diabetic group for overall 
mortality, mortality from cardiovascular causes, and cardiovascular events.44   
 
 
Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled 
Evaluation (ADVANCE) 
 
 The ADVANCE trial was a randomized controlled trial conducted in 11,140 patients with 
type 2 diabetes.  Additional inclusion criteria for study participation were diagnosis of 
type 2 diabetes at age 30 years or older and age 55 years or older at study enrollment.  
Participants were also required to have a history of major cardiovascular disease or at 
least one risk factor for cardiovascular disease.  The study participants were randomized 
to fixed dose combination of perindopril and indapamide or matching placebo, including 
current therapy.8  The ADVANCE outcomes were major macrovascular (i.e., 
cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) and microvascular 
events (i.e., new or worsening nephropathy, retinopathy).  Secondary outcomes were all-
cause mortality, cardiovascular death, major coronary events (i.e., death due to coronary 
heart disease, nonfatal myocardial infarction), total coronary events, major 
cerebrovascular events, and total cerebrovascular events.8  The ADVANCE study group 
found that significantly fewer major macrovascular or major microvascular events 
occurred during study follow-up for study participants receiving active treatment.  
Additionally, the ADVANCE data indicated that over five years, one death in every 79 
people being treated with the fixed dose perindopril-indapamide combination and one 
death due to coronary events in every 75 people on active treatment with the fixed dose 
combination would be avoided.  Active treatment was also associated with a significant 
21% reduction in total renal events and the development of microalbuminuria.8 
 
 
ADVANCE: Retinal Measurements Study (AdRem) 
 
 The ADVANCE Retinal Measurements study, a substudy of the ADVANCE trial, 
investigated whether blood pressure lowering and glucose control would improve 
retinopathy outcomes.45  The study was conducted in adults who were age 55 years or 
older at study entry and had been diagnosed with type 2 diabetes for at least 25 years.45  
Blood pressure lowering was achieved in the treatment group with combination 
perindopril and indapamide maximized to 4 mg and 1.25 mg, respectively.  Active blood 
pressure lowering with perindopril and indapamide was associated with a significant 50% 
reduction in macular edema and a 40% reduction in arteriovenus nicking compared to the 
placebo group. 
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 Though the aforementioned studies investigated different complications and outcomes 
associated with the presence of hypertension in patients with diabetes, the studies all 
indicate that the achievement of optimal blood pressure in individuals with diabetes 
results in significant reductions in morbidity and mortality.  Therefore health care 
providers should work to achieve a blood pressure of less than 130/80 mm Hg in patients 
with diabetes and concomitant hypertension. 
 
 
Relationship of Health Literacy and Health Outcomes 
 
 Functional health literacy is the ability to read and comprehend health care related 
materials necessary to successfully navigate health care.22  An interesting characteristic of 
health literacy is that it is context specific.  Therefore, an individual could have adequate 
functional health literacy with respect to their diabetes for which they are familiar with 
and have been managing for years, but could have inadequate functional health literacy 
with respect to a new diagnosis that consists of unfamiliar vocabulary and procedures.22,46  
The tests mostly commonly used to asses health literacy are the Wide Range 
Achievement Test-Revised (WRAT-R), the Rapid Estimate of Adult Literacy in 
Medicine (REALM), Medical Terminology Achievement Reading Test (MART), Slosson 
Oral Reading Test-Revised (SORT-R), the Peabody Individual Achievement Test-
Revised (PIAT-R), Instrument for the Diagnosis of Reading (IDR), and the Test of 
Functional Health Literacy in Adults (TOFHLA).47  Table 2.5 highlights various 
attributes of the four instruments most commonly seen in the literature; REALM, SORT-
R, TOFHLA, and WRAT-R. 
 
In 2003, the U.S. Department of Education, National Center for Education Statistics 
(NCES) conducted the National Assessment of Adult Literacy (NAAL).  The NAAL was 
the first assessment of American literacy since the 1992 National Adult Literacy Survey, 
and it was the first time that health literacy was examined on a national level.22,48  Health 
literacy proficiency was divided into four categories: below basic, basic, intermediate, 
and proficient.48,49  The NCES found that approximately one-third of the American 
population has basic or below basic health literacy skills.  Women were found to have an 
average health literacy score six points greater than men.  More blacks, Hispanics, and 
multiracial adults were found to have basic and below basic health literacy skills 
compared to whites and Asians/Pacific Islanders.  Additionally, individuals aged 65 years 
and older have the lowest health literacy abilities compared to all other age groups.48,49 
 
Health literacy has been consistently linked to health outcomes in the literature.  DeWalt 
et al conducted a literature review of 684 articles to determine the nature of the 
relationship between health literacy and health outcomes.50  Patients with low literacy 
were found to be 1.5 to 3 times more likely to have poorer outcomes, such as knowledge, 
intermediate disease state markers, measures of morbidity, general health status, and 
health care utilization, compared to their counterparts with adequate health literacy 
skills.50  In 2007 Paasche-Orlow et al further examined the relationship between health 
literacy and health outcomes by attempting to elucidate the causal pathways between the 
two entities.51  Paasche-Orlow et al proposed that the causal relationship between health 
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Table 2.5.  Commonly referenced health literacy instruments  
 
      Test Name 
      (Acronym) 
Aspect of 
Literacy 
Measured 
     Scale Time to 
Administer 
Advantages Disadvantages 
Rapid Estimate of 
Adult Literacy  
(REALM) – 66-
word version50,53,54 
Pronunciation 
of medical 
terms 
≤ 3rd grade, 4th 
to 6th grade, 
7th to 8th 
grade, and ≥ 
9th grade 
2 to 3 
minutes 
Uses health care 
related terms, 
quick to 
administer, highly 
correlated with 
other reading tests 
Does not measure 
reading 
comprehension, does 
not measure ability 
above 9th grade level, 
not available in 
Spanish 
 
Slosson Oral 
Reading Test – 
Revised  
(SORT–R)50,53 
Pronunciation Raw score; 
grade 
equivalents; 
age 
equivalents 
 
5 to 10 
minutes 
Can be used in 
individuals aged 4 
years old and 
older 
Small font unusable for 
patients with poor visual 
acuity, does not measure 
reading comprehension 
 
Test of Functional 
Health Literacy in 
Adults  
(TOFHLA)50,55,56 
Reading 
comprehension 
(prose literacy) 
and numeracy 
0 – 100  
Inadequate, 
marginal, and 
adequate 
TOFHLA: 
22 minutes 
Short form 
TOFHLA: 7 
minutes 
Uses health-care 
related materials, 
measures 
comprehension, 
good face 
validity, available 
in Spanish 
 
Lengthy administration, 
hard to sort out 
numeracy score from 
comprehension score 
 
Wide Range 
Achievement Test – 
Revised  
(WRAT–R)50,53 
Reading 
recognition, 
spelling, and 
arithmetic 
3rd to 12th 
grade 
3 to 5 
minutes 
Standard, quick to 
administer, well 
validated and 
studied  
Does not measure 
reading comprehension, 
not available in Spanish. 
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literacy and health outcomes is influenced by not only patient characteristics but also by 
characteristics of the health care system (i.e health care access and utilization, provider-
patient interaction, and self-care).51  Within each of these three system attributes are 
patient and system factors, such as self-efficacy and complexity of the system, that 
prohibit individuals with low health literacy from practicing preventive health care 
activities and receiving timely acute and chronic care services, thus leading to poorer 
health outcomes.51  Table 2.6 summarizes articles investigating the relationship between 
health literacy and economic, clinical, and humanistic outcomes (ECHO). 
 
 
Hypertension Knowledge Instruments in the Literature 
 
 Many studies that seek to assess an individual’s hypertension knowledge do not utilize a 
validated hypertension knowledge instrument.  Instead these studies assess a patient’s 
disease state knowledge with questions that though are derived from the literature have 
not been validated as whole to work together to accurately measure hypertension 
knowledge.13-15,17-19,31,32,52  Currently in the literature there is only one hypertension 
knowledge instrument whose psychometric properties have been assessed.16  Peters and 
Templin not only developed and assessed the psychometric properties of a hypertension 
knowledge instrument but also of an instrument measuring the performance of self-care 
behaviors of individuals with hypertension.16  For the hypertension knowledge 
instrument, individuals were asked how likely they thought a particular activity would 
control their blood pressure.  These questions were associated with a seven-point Likert 
scale anchored by the options “extremely unlikely” and “extremely likely.”  The 
hypertension self-care instrument consisted of asking respondents how often they 
perform a particular self-care behavior with answers ranging from “never” to “always.”16 
 
Even though Peters and Templin’s scale exhibited acceptable validity (Cronbach’s  
alpha = 0.90), there were limitations associated with its development.  First, the Peters 
and Templin’s blood pressure knowledge scale asked respondents how likely they believe 
that a self-care behavior would control their blood pressure.  This type of question does 
not address knowledge but rather addresses outcome expectancy.  Outcome expectancy is 
the belief that the engagement in a certain self-care behaviors will lead to an 
improvement in a health condition.85  Given this definition, Peters and Templin’s 
hypertension knowledge scale gives an idea of an individual’s intention to perform 
behavior but does not assess whether the individual knows the correct behavior in which 
to engage.  Additionally, both of Peters and Templin’s scales were developed for an 
African American population.  Though this is not a limitation per se, it does limit the 
validity of the scale in other ethnic populations.  The authors also note in their work that 
the questions were written with African American cultural influences in mind.  Therefore, 
the wording of the questions could be interpreted and answered differently depending on 
the cultural background of the respondent. The hypertension knowledge instrument for 
this study was developed with the limitations of the Peters and Templin scale in mind. 
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 Table 2.6.  Studies evaluating relationship between health literacy and ECHO 
 
Source    Objective    Sampling Study Design Health 
Literacy 
Instrument 
     Major Findings 
Economic and Humanistic     
Baker et 
al57 
To investigate 
the relationship 
between health 
literacy and self-
reported health 
and use of health 
services 
English and 
Spanish-
speaking 
adults 
n = 2,659 
Cross-sectional TOFHLA Patients with inadequate 
health literacy were more 
likely to report poor health 
status and to report being 
hospitalized in the previous 
year compared to those with 
adequate health literacy. 
 
Baker et 
al58 
To determine the 
association 
between health 
literacy and risk 
of hospitalization 
Adults aged 
18years and 
older with 
English as the 
primary 
language 
n = 958 
Prospective TOFHLA Patients with inadequate 
health literacy were more 
likely to have been 
hospitalized at least once 
between 1994–1995 
compared to those with 
marginal or adequate health 
literacy. 
 
Baker et 
al59 
To explore the 
relationship 
between health 
literacy and the 
risk of hospital 
admission 
among Medicare 
enrollees 
New Medicare 
enrollees aged 
65 years and 
older who 
were English 
or  Spanish 
speaking 
n = 3,260 
Prospective TOFHLA Patients with inadequate 
health literacy were more 
likely to report poor health 
status than those with 
adequate health literacy and 
were more likely to be 
hospitalized. 
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Table 2.6.  (continued) 
 
Source    Objective  Sampling Study Design Health 
Literacy 
Instrument 
     Major Findings 
Baker et al60 To determine 
whether low 
health literacy 
adversely affects 
use of physician 
outpatient 
services 
Medicare 
enrollees 
aged 65 
years and 
older 
n = 3,260 
Retrospective S-TOFHLA Patients with inadequate 
health literacy are more likely 
to have an emergency 
department visit.  Health 
literacy was not associated 
with mean number of 
outpatient visits or time to 
first visit. 
 
Scott et al61 To determine 
whether 
Medicare 
enrollees with 
inadequate 
health literacy 
were less likely 
to utilize 
preventive health 
care services 
 
English or 
Spanish-
speaking 
Medicare 
enrollees 
aged 65–79 
years  
n = 2,722 
 
Prospective S-TOFHLA Lack of preventive health 
care service utilization was 
higher among those with 
inadequate health literacy. 
Weiss et al62 To determine 
whether low 
literacy is 
associated with 
increased health 
care charges 
English or 
Spanish-
speaking 
adult 
Medicaid 
enrollees 
n = 74 
 
Retrospective  IDR Limited literacy was 
associated with increased 
health care charges compared 
to those with adequate 
literacy skills. 
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Table 2.6.  (continued) 
 
Source    Objective   Sampling Study Design Health 
Literacy 
Instrument 
     Major Findings 
Diabetes      
Endres et al63 To investigate 
the association 
between 
functional health 
literacy and 
pregnancy 
preparedness in 
women with 
pregestational 
diabetes 
 
English and 
Spanish-
speaking 
pregnant 
women with 
pregestational 
diabetes 
n = 74 
Cross-sectional S-TOFHLA Women with inadequate 
health literacy more likely 
to have unplanned 
pregnancy and less likely to 
have discussed pregnancy 
ahead of time with an 
endocrinologist or 
obstetrician or taken folic 
acid. 
Grubbs et al64 To examine the 
relationship 
between health 
literacy and 
access to the 
kidney transplant 
wait-list 
 
Non-Hispanic 
blacks and 
whites aged 
21 to 75 
years 
n = 62 
Retrospective S-TOFHLA Patients with inadequate 
health literacy were 78% 
less likely to receive 
transplant evaluation than 
those with adequate health 
literacy. 
Morris et al65 To determine the 
association 
between literacy 
and various 
health outcomes 
in adults with 
diabetes 
English-
speaking 
adults with 
diabetes 
n = 1,002 
Cross-sectional S-TOFHLA No significant association 
between health literacy and 
health outcomes or diabetes 
complications was found. 
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Table 2.6.  (continued) 
 
Source     Objective    Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Rothman et al66 To investigate the 
role of literacy in 
patients with 
poorly controlled 
diabetes  
Adult patients 
with type 2 
diabetes and 
HbA1c  ≥ 8.0% 
n = 159 
Prospective REALM Health literacy was not a 
significant predictor of 
improvement in HbA1c 
levels of patients with 
type 2 diabetes. 
 
Schillinger et al67 To examine the 
relationship 
between health 
literacy and 
diabetes 
outcomes among 
patients with type 
2 diabetes 
English and 
Spanish-
speaking adults 
aged 30 years 
and older with 
type 2 diabetes 
n = 408 
Cross-sectional S-TOFHLA For each 1 point 
decrease in S-TOFHLA, 
the HbA1c increased by 
0.02.  Patients with 
inadequate health 
literacy were less likely 
to have tight glycemic 
control and were more 
likely to have poor 
glycemic control than 
those with adequate 
health literacy. 
 
Schillinger et al68 To determine 
whether health 
literacy mediates 
the literacy 
between 
education and 
health outcomes 
in patients with 
diabetes 
English and 
Spanish-
speaking adults 
aged 30 years 
and older with 
type 2 diabetes  
n = 395 
Cross-sectional S-TOFHLA Literacy mediated the 
relationship between 
education and health 
outcomes. 
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Table 2.6.  (continued) 
 
Source    Objective    Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Tang et al69 To examine the 
relationship 
between health 
literacy and 
diabetic control in 
patients with type 2 
diabetes 
Chinese adults 
aged 18 years and 
older with type 2 
diabetes 
n = 149 
Descriptive S-TOFHLA 
translated 
into 
Chinese 
Increased health 
literacy was associated 
with decreased HbA1c. 
Asthma      
Mancuso et al70 To determine the 
association 
between health 
literacy and 
longitudinal 
outcomes in 
patients with 
asthma 
English-speaking 
adults with 
asthma 
n = 175 
Prospective TOFHLA Less health literacy 
was associated with 
worse quality of life, 
worse physical 
function, and having 
been treated for asthma 
in the emergency 
department during the 
study period. 
 
Williams et al71 To assess the 
relationship 
between health 
literacy and asthma 
knowledge and the 
ability to use a 
metered dose 
inhaler 
English-speaking 
adults aged 18 
years and older 
with a > 3 month 
history of asthma 
and no diagnosis 
of COPD 
n = 273 
Cross-sectional REALM Low health literacy 
was associated with 
poorer knowledge and 
improper metered dose 
inhaler technique. 
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Table 2.6.  (continued) 
 
Source    Objective   Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Mental Health      
Gazmararian et al72 To determine 
whether older 
adults with 
inadequate health 
literacy are more 
likely to report 
depressive 
symptoms 
English or 
Spanish-
speaking adult 
new Medicare 
enrollees aged 
65 years and 
older 
n = 3,171 
 
Prospective S-TOFHLA After controlling for 
health status, individuals 
with inadequate health 
literacy were not more 
likely to be depressed. 
Lincoln et al73 To examine the 
relationship 
between health 
literacy, addiction 
severity, 
depressive 
symptoms, and 
mental health 
functioning 
among people 
with drug and 
alcohol 
dependence 
English or 
Spanish-
speaking 
individuals older 
than 17 years 
who report 
alcohol, heroine, 
or cocaine as 
substance of 
first choice 
n = 380 
 
Prospective REALM Lower health literacy 
was associated with 
higher depressive 
symptoms.  Lower 
health literacy was not 
associated with 
addiction severity or 
mental health related 
quality of life. 
 
 29 
Table 2.6.  (continued) 
 
Source    Objective    Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Sexually Transmitted Diseases     
Barragan et al74 To determine the 
relationship 
between health 
literacy and 
acceptance of 
HIV testing 
English-
speaking adults 
aged 18 to 65 
years not 
known to be 
HIV positive 
n = 372 
Cross-sectional REALM Patients with low health 
literacy were more 
likely to get HIV testing 
if recommended by a 
health care provider 
than those with 
adequate health literacy. 
 
Fortenberry et 
al75 
To examine the 
relationship 
between health 
literacy and the 
receipt of a 
gonorrhea 
screening test 
 
Individuals 
aged 12 to 55 
years  
n = 890 
Cross-sectional REALM Increased health literacy 
was associated with 
greater odds of having 
had a gonorrhea test in 
the past year. 
Kalichman et al76 To determine 
whether health 
literacy is 
associated with 
health status and 
health-related 
knowledge in 
people living 
with HIV-AIDS 
 
English-
speaking adult  
men and 
women infected 
with HIV 
n = 339 
Cross-sectional TOFHLA Lower health literacy 
was associated with 
lower CD4 counts, 
higher viral loads, lower 
likelihood to be taking 
antiretrovirals, 
increased 
hospitalizations, and 
poorer self-reported 
health status. 
 30 
Table 2.6.  (continued) 
 
Source    Objective Sampling Study Design Health 
Literacy 
Instrument 
   Major Findings 
Nokes et al77 
 
To determine 
the impact of 
health literacy 
on body change 
distress, 
depressive 
symptoms, and 
HIV symptom 
intensity in 
persons living 
with HIV-AIDS 
 
Community-
dwelling, 
English-
speaking 
adults known 
to be HIV 
positive 
n = 489 
Cross-sectional REALM Lower health literacy 
was associated with 
increased reported 
body change distress, 
more depressive 
symptoms, and 
increased HIV 
symptom intensity. 
Paasche-Orlow et al78 To determine 
whether low 
health literacy is 
associated with 
worse adherence 
to antiretroviral 
therapy and less 
frequent viral 
load suppression 
English or 
Spanish-
speaking 
adults with 
HIV who 
answered at 
least two 
CAGE 
questions 
positively 
n = 235 
 
Prospective REALM Lower health literacy 
was associated with 
increased adherence 
and more frequent 
virologic suppression. 
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Table 2.6.  (continued) 
 
Source     Objective    Sampling Study Design Health 
Literacy 
Instrument 
     Major Findings 
Elderly      
Baker et al79 To determine 
whether low 
literacy is 
associated with 
overall and cause-
specific mortality 
 
New Medicare 
enrollees aged 
65 years and 
older 
n = 3,260 
Prospective 
 
TOFHLA Enrollees with inadequate 
or marginal health literacy 
were more likely to die 
than those with adequate 
health literacy. 
 
Sudore et al80 To assess the 
relationship 
between limited 
literacy and 
mortality 
Black and white 
Medicare men 
and women aged 
70–79 years 
n = 2,512 
 
Prospective REALM Enrollees with inadequate 
health literacy had higher 
all-cause mortality than 
those with adequate health 
literacy. 
Wolf et al79 To determine the 
association 
between health 
literacy, physical 
and mental health 
functioning, and 
health related 
activity limitations 
English or 
Spanish-
speaking new 
Medicare 
enrollees aged 
65 years and 
older 
n = 2,923 
Cross-sectional TOFHLA Enrollees with inadequate 
health literacy had worse 
physical functioning and 
mental health.  Enrollees 
with inadequate health 
literacy had higher rates of 
hypertension, diabetes, 
heart failure, and arthritis. 
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Table 2.6.  (continued) 
 
Source      Objective     Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Anticoagulation      
Fang et al81 To determine 
whether health 
literacy is associated 
with warfarin 
knowledge, 
adherence, and 
warfarin control 
English, 
Spanish, or 
Cantonese-
speaking adults 
aged 18 years 
and older who 
had been taking 
warfarin 
continuously for 
3 months 
n = 179 
 
Cross-sectional S-TOFHLA Limited health literacy 
was associated with 
decreased warfarin-
related knowledge.  
Limited literacy was 
not associated with 
adherence or time 
within therapeutic INR 
range. 
Cancer      
Lindau et al82 To determine 
whether health 
literacy is predictive 
of adherence to 
cervical cancer 
screenings 
English-
speaking 
women with 
abnormal pap 
smears aged 18 
years and older 
n = 68 
 
Prospective REALM Women perceived by 
their physician to have 
low literacy were less 
likely to adhere to 
cervical cancer 
screening follow-ups. 
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Table 2.6.  (continued) 
 
Source       Objective    Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Miller et al83 To determine whether 
low literacy affects a 
patients knowledge or 
receipt of colorectal 
cancer screening 
English-
speaking adults 
aged 50 years 
and older 
n = 50 
 
Cross-sectional REALM Low literacy did 
not affect receipt of 
colorectal cancer 
screening. 
Peterson et al84 To determine if health 
literacy is associated 
with knowledge of 
colorectal cancer and 
screening tests, 
perceived risks and 
benefits of colorectal 
cancer screening tests, 
perceived risk of 
colorectal screening, 
self-efficacy for 
completing screening 
tests, and receipt of 
colorectal cancer 
screening tests 
English-
speaking 
Tenncare or 
Medicare 
enrollees aged 
50 years and 
older  
n = 99 
Cross-sectional REALM Limited health 
literacy was 
associated with 
report of more 
barriers to the 
receipt of fecal 
occult blood test 
and colonoscopy. 
 
 
 34 
Table 2.6.  (continued) 
 
Source    Objective Sampling Study Design Health 
Literacy 
Instrument 
Major Findings 
Cardiovascular      
Gazmararian et al31 To examine the 
relationship 
between health 
literacy and 
disease state 
knowledge 
 
Medicare 
enrollees 
n = 214 
Cross-sectional S-TOFHLA Mean hypertension 
knowledge scores were 
lower for those with 
inadequate health 
literacy compared to 
those with adequate 
health literacy skills. 
 
Pandit et al52 To determine 
whether health 
literacy mediates 
the relationship 
between 
education, 
hypertension 
knowledge, and 
hypertension 
control 
English-
speaking 
adults aged 
18 years and 
older with a 
diagnosis of 
hypertension 
n = 330 
Cross-sectional S-TOFHLA Limited health literacy 
was associated with 
decreased hypertension 
knowledge.  Patients 
with lower literacy 
were less likely to have 
control of their blood 
pressure.  Health 
literacy did mediate the 
relationship between 
health literacy and 
hypertension control 
but did not reduce the 
association to 
nonsignificant. 
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Table 2.6.  (continued) 
 
Source      Objective  Sampling   Study Design Health 
Literacy 
Instrument 
Major Findings 
Williams et al32 To examine the 
relationship between 
health literacy and 
knowledge of chronic 
disease and the 
treatment of chronic 
disease 
English or 
Spanish-
speaking 
adults aged 
18 years and 
older with 
diabetes or 
hypertension 
n = 402 
Cross-sectional TOFHLA Patients with 
inadequate health 
literacy were less likely 
to answer a 
hypertension 
knowledge question 
correctly compared to 
those with adequate 
health literacy.  Blood 
pressure control was 
not associated with 
health literacy. 
 
Notes:  ECHO indicates economic, humanistic, and clinical outcomes; HbA1c, hemoglobin A1c; IDR, Instrument for the 
Diagnosis of Reading; INR, international normalized ratio; REALM, Rapid Estimate of Adult Literacy in Medicine; TOFHLA, 
Test of Functional Health Literacy in Adults; S-TOFHLA, short form Test of Functional Health Literacy in Adults.
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Relationship of Hypertension Knowledge and Hypertension Outcomes 
 
 Many studies have examined the relationship between hypertension knowledge and other 
factors such as education, awareness, attitude, and health literacy.13-15,17-19,31,32,52   
Unfortunately, no study has investigated the relationship between hypertension 
knowledge and outcomes.  The ITHBC purports that not only do an individual’s beliefs 
about a disease affect their willingness and ability to engage in self-care behaviors, but 
knowledge about the disease state and the self-care behaviors associated with the disease 
are also important factors in self-care behavior engagement and ultimately improvement 
in hypertension outcomes.20  However, more work needs to be done to further understand 
the relationship between hypertension knowledge and outcomes.  
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Chapter 3. Methodology  
 
 
 The primary purpose of the study was to develop and validate an instrument that assesses 
the knowledge required of an individual to successfully manage his/her hypertension.  In 
order to achieve this purpose a two-part cross-sectional study modeled after instrument 
development and validation studies by Schaffer et al and Gourley et al was used.86,87  The 
secondary purpose of the study was to determine the association between scores on the 
hypertension knowledge instrument and various outcomes and complications of 
hypertension. 
 
 
Research Design  
 
 
Phase One 
 
 The study’s phase one purpose was to assess the content validity of the instrument.  
Therefore, the instrument was provided to five experts in the areas of the treatment of 
hypertension, patient education with respect to chronic disease states, and instrument 
construction.  The experts evaluated each item for succinctness, relevance, and 
readability.  Instrument items were deleted or rewritten based on the experts’ evaluations 
of the initial instrument. 
 
 
Phase Two 
 
 A convenience sample of 200 hypertensive subjects was recruited to refine the initial 
instrument.  These initial subjects were asked to complete the demographic, medical, and 
social history questions along with the S-TOFHLA and the hypertension knowledge 
instrument. An item analysis was performed to calculate the difficulty and variance of the 
questions comprising the hypertension knowledge instrument.  Additionally, an item 
analysis was performed to determine the item-total correlation of the hypertension 
knowledge instrument questions.  Items with negative item-total correlations (measuring 
a different construct than the other items) or close to zero item-total correlations (no 
relationship between the item and the remaining items) were considered for removal from 
the instrument.88  Internal consistency was assessed using the Kuder-Richardson formula 
20 (KR-20) on the initial hypertension knowledge instrument and the refined 
instrument.88  In addition to the KR-20, the 95% confidence interval for the KR-20 was 
determined.  Exploratory factor analysis (EFA) with varimax rotation was performed to 
aid in the refinement of the initial hypertension knowledge instrument and to identify the 
number of factors or components in the final hypertension knowledge instrument.  
Confirmatory factor analysis (CFA) was used to test the factor structure identified in the 
EFA.88 
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Settings and Subjects 
 
 
Study Setting 
 
 The data were collected at a family medicine clinic associated with a southeastern United 
States health science center and a private hospital.  The clinic focused on serving health 
needs that ranged from newborn care to preventive and chronic disease care.  Patient care 
was provided by board-certified physicians, nurse practitioners, pharmacists, and resident 
physicians.89  
 
 
Sampling Plan 
 
 The study sample was drawn as a convenience sample of patients at the family medicine 
clinic.  The investigator chose this method due to the limitations of study time and 
resources. 
 
 
Subject Inclusion Criteria 
 
 The inclusion criteria for the study were the following: (1) 18 years of age and older, (2) 
diagnosis of hypertension (ICD-9 codes 401-essential hypertension, 402-hypertensive 
heart disease, 403-hypertensive kidney disease, 404-hypertensive heart and kidney 
disease), and (3) self-reported ability to read, write, speak and comprehend English. 
 
 
Subject Exclusion Criteria 
 
 The exclusion criteria for the study were the following: (1) family member enrolled in the 
study, (2) currently participating in another study, (3) pregnancy, and (4) diagnosis of 
secondary hypertension (ICD-9 code 405). 
 
 
Instrumentation and Operationalization of Variables 
 
 
Hypertension Knowledge Instrument 
 
 The initial instrument was a 14 item multiple-choice assessment based on the seventh 
report of the Joint National Committee on Prevention, Detection, Evaluation and 
Treatment of High Blood Pressure (JNC-7), knowledge instruments from the Tennessee 
Pharmacists Association and the American Heart Association, and previous research 
(Appendix A).16,24,90,91  The items of the instrument were written to correspond with four 
areas of self-care behaviors identified in the literature as important to the management of 
hypertension.  These domains were hypertension and its risk factors, diet/alcohol and 
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tobacco use, blood pressure medications, and complications of hypertension.  Before 
administering the hypertension knowledge instrument, the Flesch-Kincaid method was 
used to assess the reading ease and grade level of the instrument.  The knowledge 
instrument was scored as the number of questions answered correctly. 
 
 
Functional Health Literacy 
 
 The S-TOFHLA was used with permission to measure the functional health literacy of 
the study participants (Appendix A).  The TOFHLA is a recognized and accepted 
measure of functional health literacy.  The TOFHLA seeks to quantify functional health 
literacy by examining not only reading comprehension but also numeracy.55  The S-
TOFHLA was used as a variable to not only examine the relationship between scores on 
the hypertension knowledge instrument and the scores on the S-TOFHLA, but also a 
potential confounder in determining the relationship between scores on the hypertension 
knowledge instrument and the presence or absence of one or more complications 
associated with hypertension. 
 
 Due to the time constraints associated with this study and the administration of the 
TOFHLA (20–30 minutes), the S-TOFHLA was administered (5–7 minutes).  The 
passages for the S-TOFHLA are taken from instructions for the preparation for an upper 
gastrointestinal procedure and from the “Rights and Responsibilities” section of a 
Medicaid form.55  The S-TOFHLA utilizes the Cloze procedure in order to assess the 
functional health literacy of an individual.  The Cloze procedure involves the replacement 
of every fifth to seventh word in a passage with a blank and multiple choices for the 
correct word.  The individual taking the test must then decide on the appropriate word for 
the blank based on the grammar and context of the passage.55  The scores on the S-
TOFHLA range from 0 to 36 with scores ranging from 0 to 16 indicating inadequate 
functional health literacy, 17 to 22 indicating marginal health literacy, and 23 to 36 
indicating adequate health literacy.30  
 
 
Operationalization of Variables 
 
 
Response Variables 
 
 The response variables for the logistic regression models were the study participants’ 
clinical outcomes, systolic blood pressure (SBP), diastolic blood pressure, (DBP), Scr, 
HbA1c, and the presence or absence of complications associated with hypertension.  
Though an individual’s blood pressure was collected as a continuous variable, blood 
pressure was operationalized as a two-category nominal variable, at goal or not at goal.  
Because health care providers seek to attain blood pressure goals as determined by the 
JNC-7 guidelines, this two-category operationalization of blood pressure was deemed 
appropriate for this study.  A blood pressure less than 140/90 mm Hg was categorized as 
at goal for individuals who did not have type 1 or type 2 diabetes and less than 130/80 
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mm Hg for participants with type 1 or type 2 diabetes.  A blood pressure greater than or 
equal to 140/90 mm Hg for individuals without type 1 or type 2 diabetes or 130/80 mm 
Hg for individuals with type 1 or type 2 diabetes was categorized as not at goal. 
 
 Serum creatinine was collected as a continuous variable.  However in order to use Scr in 
the logistic regression model, it was operationalized as a two-category nominal variable.  
Therefore, a Scr value greater than 1.4 mg/dL was categorized as high and a value less 
than or equal to 1.4 mg/dL was categorized as within normal limits. 
 
 Hemoglobin A1c was collected as a continuous variable.  In order to use HbA1c in the 
logistic regression model, HbA1c was operationalized as a two-category nominal 
variable.  Therefore, a HbA1c value greater than or equal to 7% was categorized as high 
and a value less than 7% was categorized as within normal limits. 
 
 The presence or absence of complications associated with hypertension was assessed by 
asking the study participants “Do you have or have you been told that you have any of 
the following?”  Study participants were asked to check all that apply from the following 
options: congestive heart failure, stroke, myocardial infarction (heart attack), peripheral 
vascular disease, end stage renal disease, type 1diabetes, type 2 diabetes, and 
hyperlipidemia. 
 
 
Explanatory Variables 
 
 Because individuals can be reluctant to disclose their age, study participants’ ages were 
assessed by obtaining his/her date of birth and then subtracting this date from the date 
that the participant completed the questionnaire.  Gender was operationalized as a two-
category nominal variable, male and female. 
 
 Race was operationalized as a five-category nominal variable, white/Caucasian, 
black/African American, American Indian/Alaskan native, Asian/Pacific Islander, and 
other.  The study participant was asked to specify a race if the individual chose other as a 
response for the race question.  Additionally, ethnicity was measured as a two-category 
nominal variable, Hispanic and non-Hispanic.  However, because only two respondents 
indicated Hispanic as their ethnicity, ethnicity was not included in the logistic regression 
analysis for this research. 
 
 Respondents’ level of educational attainment was measured as an eight-category nominal 
variable: less than high school, some high school, high school diploma/GED, some 
college, associate’s degree, bachelor’s degree, master’s degree, or doctorate/professional 
degree.  Level of educational attainment was collected as a measure of social facilitation 
in the ITHBC. 
 
 Respondents’ insurance status was measured as a six-category nominal variable: 
TennCare, Medicare, TennCare and Medicare, other, Medicare and other, and self-pay.  
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Respondents’ insurance status was collected as a measure of social facilitation in the 
ITHBC. 
 
 Respondents’ marital status was collected as an additional measure of social facilitation.  
Marital status was operationalized as a two-category nominal variable: yes or no. 
 
Duration of hypertension diagnosis was measured as a six-category ordinal variable: (1) 
less than one year, (2) one to five years, (3) six to ten years, (4) eleven to fifteen years, 
(5) sixteen to twenty years, or (6) greater than 20 years.  Respondents’ hypertension 
diagnosis duration was collected due to the potential for confounding between it and 
knowledge of hypertension and hypertension self-care behaviors.  It was believed that the 
longer the duration of disease the higher the score on the hypertension knowledge 
instrument. 
 
 As a measure to control for the effect that previous education about hypertension could 
have on respondents’ hypertension knowledge instrument scores, respondents were asked 
“Has anyone provided you with information about your high blood pressure?” 
Respondents were provided with a two-category nominal response option: yes or no. 
 
 Engagement in self-care behavior management was operationalized using the following 
open-ended questions: “Do you monitor your salt intake?”; “How often (times per week) 
do you engage in physical activity?”; “What kind of physical activity do you engage in?”; 
and “How long do you engage in physical activity?” 
 
 The S-TOFHLA, as previously stated, was used as a measure of respondents’ functional 
health literacy status.  Scores on the S-TOFHLA were operationalized two different 
ways.  The first involved categorizing the data into the following three-category nominal 
variable: scores of 0 to 16 were categorized as inadequate health literacy, scores of 17 to 
22 were categorized as marginal health literacy, and scores of 23 to 36 were categorized 
as adequate health literacy.  Although in the literature increasing functional health 
literacy is associated with increased disease state knowledge, inconsistencies still exist.  
For example, individuals with marginal or adequate functional health literacy skills 
possess increased disease state knowledge over those with inadequate functional health 
literacy skills.  However, individuals with adequate functional health literacy skills do not 
consistently posses increased disease state knowledge compared to their counterparts 
with inadequate functional health literacy skills.  Because of these inconsistencies, 
functional health literacy was operationalized by categorizing the data into the following 
two-category nominal variable: scores of 0 to 16 as inadequate health literacy and scores 
of 17 and above as marginal/adequate health literacy.31 
 
 
 Study Procedures 
 
The interview flow, Figure 3.1, for this study was adapted from a previous study by Yang 
(Appendices A and B).92  Although, the interview flowchart indicates that the S-
TOFHLA was administered prior to the demographic and hypertension knowledge  
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Figure 3.1.  Flowchart of interview procedures 
 
Modified with permission. Yang Y. African Americans' responses to direct-to-consumer 
advertising of prescription drugs [dissertation]. 2004. University of Tennessee Health 
Science Center, p. 69. 
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instrument questions, the flow was reversed to ensure completion of the hypertension 
knowledge instrument.  Since the hypertension knowledge instrument was the data source 
for the primary study objective, this reversal was deemed necessary.  The investigator 
met with practitioners at the study site before beginning the study.  Site practitioners 
agreed to allow the investigator to come to the site on clinic days.  Individuals were 
identified as having hypertension by the clinic health care professional that was 
responsible for his/her care.  The health care professional then directed the patient to the 
investigator.  Upon meeting with the potential study participant, the investigator applied 
the aforementioned inclusion and exclusion criteria.  If the potential participant met the 
inclusion criteria, the individual was asked to participate in a study investigating an 
individual’s knowledge about hypertension or high blood pressure.  Additionally, if the 
individual chose not to participate, the potential participant was thanked and not asked to 
complete the study.  Individuals who agreed to participate in the study were read the 
demographic questionnaire and the hypertension knowledge instrument and the 
investigator recorded their answers.  Upon completion of the demographic questionnaire 
and the hypertension knowledge instrument, participants were asked to self-complete the 
S-TOFHLA.  If the individual chose not to participate, the investigator recorded the 
reason provided for not attempting the S-TOFHLA. 
 
 
Statistical Analysis 
 
 
Sample Size Estimation  
 
 Currently, there are not any agreed upon sample size estimations in the literature for 
factor analysis.  Therefore, the investigator adhered to Pett et al’s recommendation of 
having at least 10 subjects per item in the hypertension knowledge instrument.88  For the 
logistic regression analysis, the generally accepted rule of ten subjects per predictor 
variable was utilized.  Based on this rule, a minimum sample size of 120 was needed.93 
 
 
Data Analysis 
 
 
Descriptive Statistics 
 
 Frequencies and means were determined for the demographic and medical history 
questions.  For continuous variables, means and standard deviations were reported.  For 
nominal and ordinal variables, percentages were reported.  Additionally, means (p) and 
variances (pq) were calculated for each item of the instrument.  The item mean, p, is an 
indicator of item difficulty and represents the proportion of people who answered the 
particular item correctly and ranges between zero and one for a dichotomously scored 
question.94  The closer an item mean is to zero the more difficult the question is assumed 
to be.  The item variance, pq, was obtained by multiplying the proportion of people who 
answered an item correctly by the proportion of people who answered the item 
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incorrectly.94    In addition to calculating the means and variances for each item, the mean 
and variance were determined for the instrument as a whole.  The instrument mean was 
determined by summing the individual item means.  The instrument variance was 
calculated using the following equation: 
 
σ2 = Σσi2 + 2Σcovij 
 
where σ2 is the instrument variance, σi2 is an item variance, and covij is the covariance 
between two items.94 
 
 
Kuder-Richardson 20 (KR-20) 
 
The Kuder-Richardson 20 (KR-20) formula is a deviation of the Cronbach’s coefficient 
alpha that substitutes the variance of a dichotomously scored item, pq, for the variance of 
a continuously scored question.  Like Cronbach’s coefficient alpha, KR-20 is a measure 
of reliability that takes into account common variance.88  Even though KR-20 is generally 
accepted as the standard measure of internal consistency it is important to remember that 
the value of KR-20 increases as the length of the scale increases.  In accordance with the 
literature, a KR-20 lower bound of 0.70 was chosen.27,87 
 
 
Factor Analysis 
 
 
Exploratory Factor Analysis 
 
 Exploratory factor analysis was used in this study to determine the underlying factor 
structure of the domain of interest, hypertension knowledge.  When deciding to conduct 
exploratory factor analysis, there are two different methods to carry out the analysis: 
principal component analysis and principal axis factoring.  Although both of these 
methods are variable reduction methods, they differ in their underlying assumptions.  
Principal component analysis makes no assumption regarding the underlying latent 
variables whereas factor analysis assumes that the latent variables are correlated.95  
Principal axis factoring was the method chosen to conduct the exploratory factor analysis 
because it gave a cleaner solution than the principal component analysis method.  
Varimax rotation was chosen for the exploratory factor analysis.  Varimax rotation makes 
high loadings higher and low loadings lower in order to maximize the difference between 
loadings.88  The advantages of using varimax rotation is that its solutions are clearer and 
more easily interpreted.  Additionally, the variances do not overlap with varimax 
rotation.88  The disadvantage of using a varimax rotation is that it makes it difficult to 
determine an overall factor structure.88  The correlation matrix of the final data set was 
used as the input matrix.  An eigenvalue greater than or equal to one along with the 
results of the scree plot and item loadings greater than or equal to 0.3 were was used to 
select the number of factors present. 
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Confirmatory Factor Analysis 
 
 Confirmatory factor analysis, performed using SAS Proc Calis, was conducted in this 
study to investigate the factor structure identified in the exploratory factor analysis.  SAS 
Proc Calis performs latent variable structural equation modeling (SEM).  However, 
instead of using a SEM, a latent variable (measurement) structure was performed.  The 
latent variable structure was used because only the structure of the loadings on the factor 
structure was tested.  No test of the relationships between the factors or latent variables 
was conducted. 
 
 
Regression Analysis 
 
 Regression analysis was employed in this study to understand the association between 
various clinical outcomes, including blood pressure, Scr, and HbA1c, and scores on the 
hypertension knowledge instrument.  Additionally, the relationship between the presence 
or absence of certain comorbid conditions and complications and scores on the 
hypertension knowledge instrument were also investigated using regression analysis.  
Potential explanatory variables or confounders for the study included age, race, scores on 
the S-TOFHLA, duration of hypertension, previous hypertension education, and spouse 
or family member with hypertension.  In order to fully investigate the relationship 
between the clinical outcomes and scores on the hypertension knowledge instrument, a 
logistic regression analysis with clinical outcomes operationalized as categorical 
variables was conducted.  Logistic regression was chosen as the method of analysis due 
to its use of the outcome variable as a binary variable.  For this research, the outcome 
variable was operationalized as either at goal or not at goal or within normal limits or not.  
This operationalization was deemed appropriate as health care providers adhere to 
clinical guidelines when treating hypertensive patients and seek to treat patients to goal or 
within normal limits.  Only predictor variables with a p-value of 0.05 or less were 
deemed significant. 
 
 
Consideration of Human Subjects 
 
 The study was granted expedited status by the institutional review board (IRB) at the 
investigator’s institution.  Additionally, the IRB approved an alteration of participant 
consent.  Therefore, a cover letter was used instead of the traditional informed consent 
form to consent patients.  By participating in the study, the participants consented to not 
only their participation but also to the access of their medical records for the collection of 
study data points.  Approval to conduct the study and access to medical records were 
granted by the clinic institutional review board.  All information associated with the study 
and the participants were securely protected.  Participants who chose not to participate in 
the study were not asked to complete the study questionnaires (Appendix B). 
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Chapter 4. Results 
 
 
Study Sample Characteristics 
 
 Two hundred subjects were recruited for the study.  However, due to missing data 196 
were included in the analysis.  The study sample characteristics are listed in Table 4.1.  
The mean age of the study sample was 54 years.  Seventy-four percent of the study 
sample was comprised of females.  The self-reported race of study participants was 77% 
African American/black, 22% Caucasian/white, and 1% Asian/Pacific Islander.  Over 
three-quarters of the study sample had a high school diploma or the equivalent or higher, 
with 15.3% of the study sample having earned a bachelor’s or master’s degree.  The 
mean systolic blood pressure was 139.64 mm Hg and the mean diastolic blood pressure 
was 82.98 mm Hg.  Almost half of the study sample had had a diagnosis of hypertension 
for either one to five years (27.6%) or greater than 20 years (22.4%).  Additionally, 
nearly 70% of the study population had received previous education about hypertension 
and the self-care behaviors necessary to effectively and successfully manage and treat 
high blood pressure.  The average number of blood pressure medications being taken by 
study participants was 2.16, with a range from zero medications to six medications. 
 
 
Instrument Scoring 
 
 Respondent’s correct answers were scored as one and incorrect answers were scored as 
zero.  If a respondent failed to answer a knowledge question, the item was scored as zero.  
Additionally, if a respondent indicated multiple answers for a question, the item was 
scored as incorrect and thus was given a score of zero.  Question 6, which asked “How 
many days per week should you perform moderate intensity exercise for at least 30 
minutes?” was double-coded for three days or five days per week as the correct answers.  
Because the guidelines had just recently changed to increase the days per week of 
exercise from three days to five days, the acceptance of both these answers was 
appropriate.    Additionally, question 14, which asked “How much salt should a person 
with high blood pressure eat each day?” was double-coded for one-half and one-fourth 
teaspoonful as the correct answers.  The guidelines recommend that individuals consume 
1500 mg or less of sodium a day.  Because one-half teaspoonful is equal to approximately 
1500 mg of sodium and one-fourth teaspoonful is equal to approximately 700 mg of 
sodium, both of these answers had to be considered correct as they adhere to the 
guidelines of 1500 mg or less of sodium per day. 
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Table 4.1.   Study sample characteristics  
 
Study Sample Characteristics n = 196 Value 
Age (years), mean ± standard deviation 54.237 ± 14.509 
Sex, n (%) 
Male 
Female 
 
51 (26) 
145 (74) 
 
Race, n (%) 
Caucasian/White 
African American/Black 
Asian/Pacific Islander  
 
43 (22) 
151 (77) 
2 (1) 
 
Ethnicity, n (%) 
Hispanic 
Non-Hispanic 
 
2 (1) 
194 (99) 
 
Education, n (%) 
Less than high school 
Some high school 
High school diploma/GED 
Some college 
Associate’s degree 
Bachelor’s degree 
Master’s degree 
 
12 (6.1) 
34 (17.3) 
67 (34.2) 
37 (18.9) 
16 (8.2) 
22 (11.2) 
8 (4.1) 
 
Attempted S-TOFHLA, n (%) 
Yes 
No 
 
74 (37.8) 
122 (62.2) 
 
S-TOFHLA, n (%) 
Inadequate (0–16) 
Marginal (17–22) 
Adequate (23–36) 
 
19 (25.7) 
4 (5.4) 
51 (68.9) 
 
Insurance, n (%) 
TennCare 
Medicare  
Other 
Self 
TennCare and Medicare 
Medicare and other 
 
 
61 (31.1) 
52 (26.5) 
54 (27.6) 
7 (3.6) 
18 (9.2) 
4 (2) 
Marital status, n (%) 
Married 
Not married 
 
65 (33.2) 
131 (66.8) 
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Table 4.1. (continued) 
 
Study Sample Characteristics n = 196 Value 
Systolic blood pressure (mm Hg), mean ± standard 
deviation 
 
139.64 ± 
20.414 
 
Diastolic blood pressure (mm Hg), mean ± standard 
deviation 
 
82.98 ± 12.429 
 
Length of disease, n (%) 
Less than 1 year 
1 to 5 years 
6 to 10 years 
11 to 15 years 
16 to 20 years 
greater than 20 years 
 
14 (7.1) 
54 (27.6) 
47 (24) 
19 (9.7) 
18 (9.2) 
44 (22.4) 
 
Previous blood pressure education, n (%) 
Yes 
No 
 
136 (69.4) 
60 (30.6) 
 
Take blood pressure medication, n (%) 
Yes  
No 
 
193 (98.5) 
3 (1.5) 
 
Number of blood pressure medications, mean ± 
standard deviation 
Minimum 
Maximum 
2.16 ± 1.046 
  
0 
6 
 
Monitor salt, n (%) 
Yes 
No 
 
143 (73) 
53 (27) 
 
Exercise, n (%) 
Yes 
No 
 
108 (55.1) 
88 (44.9) 
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Item Analysis and Exploratory Factor Analysis 
 
 
Original Hypertension Knowledge Instrument 
 
 An item analysis was performed on the original 14 questions (Appendix C) of the 
hypertension knowledge instrument.  The initial Cronbach’s alpha was 0.597 (95%  
CI: 0.505, 0.672).  Table 4.2 lists the item means, variances, and standard deviations for 
the original 14 questions of the hypertension knowledge instrument.  Item three had the 
lowest mean of 0.16, indicating it to be the most difficult of the items.  Because the mean 
of item three was substantially lower than the other item means, item three was 
considered for removal from the instrument.  The original hypertension knowledge 
instrument mean was 11.15 and the variance of the instrument was 3.617. 
 
 The inter-item correlation matrix was examined to determine which items did not 
correlate well with one another.  Table 4.3 indicates that item 13 had poor inter-item 
correlation with the other items on the instrument.  Out of the 14 items on the instrument, 
item 13 had negative inter-item correlations with five other items.  Therefore, item 13 
was also considered for removal from the original instrument. 
 
 The item-total statistics, as seen in Table 4.4, were calculated in order to determine how 
each of the items correlated with the scale as a whole.  Additionally, the item-total 
statistics were examined to determine how to best improve the instrument’s Cronbach’s 
alpha.  Based on the corrected item-total correlations, items 11 and 13 were considered 
for removal from the original instrument due to their low item-total correlations 0.093 
and 0.033, respectively.  These low-item total correlations indicated poor correlation with 
the instrument as a whole. 
 
An EFA using principal axis factoring as the extraction method and varimax rotation was 
conducted.  The EFA resulted in a Kaiser-Meyer-Olkin (KMO) measure of sampling 
adequacy of 0.592, thus indicating that factor analysis was appropriate for this set of data.  
Additionally, the Bartlett’s test of sphericity, which tests the null hypothesis that the 
population correlation matrix is an identity matrix, was rejected with a p-value of 0.000, 
again indicating that factor analysis is appropriate.  Table 4.5 lists the communalities for 
each item of the instrument.  The communality of an item is the total amount of variance 
that a factor explains.88  Communalities range from zero to one.  A communality close to 
one indicates that the extracted factor explains nearly all of the item variance.88  By 
examining the resultant communalities, the variance in item three was not explained by 
the extracted factors, thereby giving more credence to the consideration for its removal 
from the instrument. 
 
The rotated factor matrix of the original hypertension knowledge instrument, which 
indicates the loading of each item on the factors extracted, is shown in Table 4.6.  As can 
be seen, the principal axis factoring method extracted 6 factors.  The following four 
criteria were used to refine the original instrument: (1) a factor loading of 0.3 or greater, 
(2) maximizing the Cronbach’s alpha, (3) maximizing of the item analysis results, and (4)  
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Table 4.2.  Item means, variances, and standard deviations for original hypertension 
knowledge instrument 
 
Item Mean (p) Variance (pq) Standard Deviation 
1 0.87 0.1131 0.334 
2 0.92 0.0736 0.275 
3 0.16 0.1344 0.366 
4 0.86 0.1204 0.351 
5 0.91 0.0819 0.290 
6 0.84 0.1344 0.371 
7 0.93 0.0651 0.258 
8 0.71 0.2059 0.453 
9 0.91 0.0819 0.290 
10 0.95 0.0475 0.221 
11 0.96 0.0384 0.186 
12 0.80 0.16 0.400 
13 0.76 0.1824 0.431 
14 0.58 0.2436 0.495 
 
Note: P indicates number of respondents who correctly answered an item; q, number of 
respondents who incorrectly answered an item.
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Table 4.3.  Original hypertension knowledge instrument inter-item correlation matrix  
 
Item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 1.00              
2 .109 1.00             
3 .082 .078 1.00            
4 .019 .251 .097 1.00           
5 -.016 .034 .041 .274 1.00          
6 .121 .120 .116 .135 .242 1.00         
7 .013 .351 .012 .170 .186 .038 1.00        
8 .097 .265 .027 .097 .112 -.004 .132 1.00       
9 .143 .163 .041 .274 .205 .051 .049 034 1.00      
10 .259 .354 .037 .170 .087 .274 .026 .059 .167 1.00     
11 -.074 .043 .083 .000 .034 -.011 .053 .061 .034 .205 1.00    
12 .154 .271 .181 .162 .019 .056 .110 .194 .196 .117 -.027 1.00   
13 .067 .047 .149 -.029 -.140 -.091 -.020 .008 -.099 .030 .146 .162 1.00  
14 .079 .125 .056 .038 .088 .073 .086 .425 .017 .038 .004 .018 -.026 1.00 
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Table 4.4.   Original hypertension knowledge instrument item-total statistics  
 
Item Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach’s 
Alpha if Item 
Deleted 
1 10.28 3.259 0.204 0.557 
2 10.23 3.134 0.419 0.524 
3 10.99 3.226 0.196 0.559 
4 10.30 3.132 0.291 0.540 
5 10.24 3.314 0.208 0.557 
6 10.32 3.233 0.186 0.561 
7 10.22 3.344 0.219 0.556 
8 10.44 2.924 0.315 0.531 
9 10.24 3.304 0.218 0.555 
10 10.20 3.312 0.320 0.545 
11 10.19 3.518 0.093 0.572 
12 10.35 3.019 0.315 0.533 
13 10.40 3.379 0.033 0.600 
14 10.57 3.005 0.214 0.561 
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Table 4.5.  Original hypertension knowledge instrument EFA communalities  
 
Item Initial Extraction 
1 0.131 0.201 
2 0.339 0.725 
3 0.080 0.138 
4 0.187 0.275 
5 0.194 0.511 
6 0.158 0.160 
7 0.179 0.231 
8 0.267 0.537 
9 0.163 0.188 
10 0.289 0.962 
11 0.110 0.268 
12 0.182 0.365 
13 0.109 0.285 
14 0.198 0.364 
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Table 4.6.  EFA rotated factor matrix of original hypertension knowledge 
instrument   
 
Item Factor 
1 2 3 4 5 6 
1 .336   .104 .215 0.173 
2 .250  .790 .139 .134  
3     .345  
4  .431 .258  .138  
5  .693  .114   
6 .253 .308     
7  .177 .423    
8   .192 .696 .115  
9 .142 .342 .128  .147 -.111 
10 .913 .147 .158   .284 
11      .507 
12 .104  .222  .521 -.141 
13  -.221   .419 .243 
14    .598   
 
 55 
theoretical soundness of the factor structure.  Based on the aforementioned criteria nine 
items were retained from the original 14 items that comprised the hypertension 
knowledge instrument.  On the first round of EFA item three was removed due to a 
substantially low item mean compared to the other items on the instrument.  Additionally, 
item 13 was also removed from the instrument due to its low item-total correlation and its 
negative inter-item correlation with 5 out of the 14 items. 
 
Once items 3 and 13 were removed from the instrument the EFA was run again on the 
remaining 12 items.  Although, the Cronbach’s alpha increased from 0.597 to 0.611, 
items 6 and 11 did not load on any of the factors that were extracted from the subsequent 
EFA.  Additionally, item 11 still had a low item-total correlation of 0.047.  Based on this 
result, another EFA was run with items 3, 6, 11 and 13 removed.  This combination of 10 
items on the hypertension knowledge instrument resulted in a further increase in the 
Cronbach’s alpha to 0.616.  Since the ten item EFA’s scree plot (Figure 4.1) indicated 
three factors present, an EFA was then run forcing the extraction of three factors.  This 
EFA resulted in all of the ten remaining items except for item seven loading on one of the 
three factors.  Since item seven did not meet the rule of a factor loading of 0.3 or higher, 
it was also removed from the instrument. 
 
 
Final Hypertension Knowledge Instrument 
 
The final hypertension knowledge instrument consisted of the following nine items: items 
1, 2, 4, 5, 8, 9, 10, 12, and 14.  The Cronbach’s alpha for the refined instrument was 
0.598 (95% CI: 0.504, 0.674).  The item means, variance and standard deviation are listed 
in Table 4.7.  The item means ranged from 0.58 to 0.95.  The refined instrument mean 
was 7.51 ± 1.524, and the instrument variance was determined to be 2.323. 
 
The inter-item correlation for the final hypertension knowledge instrument is shown in 
Table 4.8.  This correlation matrix was used as the input correlation matrix for the CFA.  
Table 4.9 shows the item-total statistics for the final knowledge instrument.  As can be 
seen, removal of any one of the items would not result in a higher Cronbach’s alpha. 
 
An EFA was conducted on the final knowledge instrument in order to determine the 
factor structure of the nine items.  The KMO measure of sampling adequacy was 0.628 
indicating that factor analysis was appropriate.  Additionally, the Bartlett’s test of 
sphericity rejected the null hypothesis that the population correlation matrix was an 
identity matrix with a p-value of < 0.001.  The communalities of the final instrument are 
shown in Table 4.10 and the final factor loadings are showing in Table 4.11.  Factor 1 
was comprised of item 8 and 14, both of which measure diet and more specifically salt 
intake knowledge.  Items 1, 2, 10, and 12 loaded onto factor 2 and measure general 
hypertension knowledge.  Finally, items four, five, and nine all measure risk factors and 
complications of hypertension and comprise factor three. 
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Figure 4.1.   Exploratory factor analysis scree plot indicating three factor structure 
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Table 4.7.  Item means, variances, and standard deviations for the refined 
hypertension knowledge instrument 
 
Item Mean (p) Variance (pq) Standard Deviation 
1 0.87 0.1131 0.334 
2 0.92 0.0736 0.275 
4 0.86 0.1204 0.351 
5 0.91 0.0819 0.290 
8 0.71 0.2059 0.453 
9 0.91 0.0819 0.290 
10 0.95 0.0475 0.221 
12 0.80 0.16 0.400 
14 0.58 0.2436 0.495 
 
Note:  P indicates number of respondents who correctly answered an item; q, number of 
respondents who incorrectly answered an item.
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Table 4.8.   Inter-item correlation matrix for final hypertension knowledge 
instrument  
 
Item 1 2 4 5 8 9 10 12 14 
1 1.00         
2 .109 1.00        
4 .019 .251 1.00       
5 -.016 .034 .274 1.00      
8 .097 .265 .097 .112 1.00     
9 .143 .163 .274 .205 034 1.00    
10 .259 .354 .170 .087 .059 .167 1.00   
12 .154 .271 .162 .019 .194 .196 .117 1.00  
14 .079 .125 .038 .088 .425 .017 .038 .018 1.00 
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Table 4.9.   Final hypertension knowledge instrument item-total statistics  
 
Item Scale Mean if 
Item Deleted 
Scale Variance 
if Item Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach’s 
Alpha if Item 
Deleted 
1 6.64 2.027 0.193 0.565 
2 6.59 1.945 0.395 0.519 
4 6.65 1.920 0.288 0.540 
5 6.60 2.077 0.195 0.564 
8 6.80 1.681 0.372 0.510 
9 6.60 2.015 0.272 0.546 
10 6.56 2.094 0.283 0.549 
12 6.71 1.869 0.269 0.546 
14 6.93 1.769 0.235 0.567 
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Table 4.10.   Final hypertension knowledge instrument EFA communalities  
 
Item Initial Extraction 
1 0.103 0.133 
2 0.250 0.365 
4 0.177 0.368 
5 0.115 0.265 
8 0.254 0.754 
9 0.142 0.233 
10 0.192 0.312 
12 0.135 0.155 
14 0.190 0.238 
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Table 4.11.  EFA rotated factor matrix of final hypertension knowledge instrument  
 
Item Factor 
 1 2 3 
1  0.362  
2 0.188 0.551 0.160 
4  0.205 0.570 
5 0.100  0.503 
8 0.850 0.167  
9  0.262 0.404 
10  0.543 0.129 
12 0.114 0.353 0.131 
14 0.483   
 
Note:  Bold type indicates the factor on which the item loaded. 
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Confirmatory Factor Analysis 
 
 A CFA was conducted in order to verify the factor structure identified from the EFA.  For 
the CFA manifest errors were assumed to be orthogonal and the following items were 
forced to load on the respective factors: item eight and factor one, item two and factor 
two, and item four and factor three.  Table 4.12 shows the results of various fit 
indices.  These fit indices indicated that the factor structure identified in the EFA and 
specified in the CFA was a good fit for the data.  The chi-square statistic tests the null 
hypothesis that the implied covariance matrix is equal to the observed covariance matrix.  
Because the CFA in this study resulted in a nonsignificant chi-square statistic, the 
investigator failed to reject the null hypothesis, thus indicating that the specified model 
did indeed fit the data.  However, because the chi-square statistic is sensitive to sample 
size, additional fit indices were also examined to determine the fit of the model.  The GFI 
and the AGFI are indices whose values range from zero to one.  The closer to one the 
better the model fit.  It is generally accepted that a GFI greater than or equal to 0.96, as 
obtained in this study, is an ideal fit of the model.   The RMR operates in the opposite 
manner than the GFI, with a RMR of less than 0.05 indicating good model fit.  Therefore, 
this study’s RMR of 0.0052 indicated good model fit.  Finally, as can be seen in Table 
4.13, factors one and two and factors two and three were significantly correlated with one 
another.  Additionally, factors one and three were not significantly correlated with one 
another. 
 
 
Logistic Regression 
 
Logistic regression was conducted to examine the relationship between adequate 
hypertension knowledge, defined as a score of 70% or higher on the hypertension 
knowledge instrument, and health outcomes such as SBP and DBP control, overall blood 
pressure control, Scr control and HbA1c control.  In order to adequately characterize the 
ITHBC, the theoretical framework of the study, eight variables were included in the 
logistic regression model.  The variable adequate hypertension knowledge was included 
in the regression model to represent knowledge and beliefs.  The variables marital status, 
level of educational attainment, and insurance status were included to represent the social 
facilitation aspect of the ITHBC.  The proxies for engagement in self-care behaviors were 
the variables whether the respondent monitors their salt intake, whether the respondent 
exercises, the number of blood pressure medications, and the number of hypertension-
related complications.  In order to comply with what has been shown in the literature the 
four variables, age, race, sex, and education were included in all of the models as 
confounders.  All of the aforementioned variables were included in the logistic regression 
model whether or not statistical significance was achieved.  Statistical significance was 
set at a p-value of 0.05 or less. 
 
Ethnicity was not included in the models because only two study participants indicated 
their ethnicity as Hispanic.  Additionally, the dummy variable for Asian/Pacific Islander 
was not included in the logistic regression models due to only two respondents reporting 
Asian/Pacific Islander as their race, and thus resulting in exceptionally large standard  
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Table 4.12. Confirmatory factor analysis fit indices 
 
Fit Index Value 
Fit function 0.1573 
Goodness of Fit Index (GFI) 0.9861 
GFI Adjusted for degrees of freedom (AGFI) 0.9425 
Root Mean Square Residual (RMR) 0.0052 
Standardized Root Mean Square Residual (SRMR) 0.0485 
Chi square, degrees of freedom, p-value 30.6741, 25, 0.2 
 
 
 
 
 Table 4.13.   Covariances among factors 
 
Variable 1 Variable 2 Parameter Estimate Standard  
Error 
t-Value 
Factor 1 Factor 2 phi12 0.02904 0.00846 3.43 
Factor 1 Factor 3 phi13 0.01551 0.01016 1.53 
Factor 2 Factor 3 phi23 0.02180 0.00628 3.47 
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errors.  Finally, the S-TOFHLA was not included in the regression models because only 
74 out of the 200 study participants completed the S-TOFHLA.  Additionally, there 
appeared to be selection bias associated with completing the S-TOFHLA as the scores 
were skewed to the left.  The mean S-TOFHLA score for the 74 participants who 
completed the S-TOFHLA was 25.34 with a range of 0 to 36. 
 
Table 4.14 shows the final regression model for systolic blood pressure control as the 
dependent variable.  No significant relationship between hypertension knowledge and 
SBP control was determined.  Two variables, length of disease and number of comorbid 
disease states, were found to have a significant relationship with systolic blood pressure 
control.  Compared to respondents who had been diagnosed with hypertension for less 
than one year, respondents who had been diagnosed with high blood pressure for 6 to 10 
years were 5.8 times more likely to exhibit systolic blood pressure control, after 
controlling for all other variables in the model.  Additionally for every one unit increase 
in the number of comorbid diseases a respondent had, they were approximately 43% less 
likely to achieve systolic blood pressure control.   
 
 Table 4.15 shows the results for the final regression model with diastolic blood pressure 
control as the dependent variable.  As in the SBP control model, hypertension knowledge 
was not significantly associated with DBP control.  The variables number of comorbid 
disease states and age achieved statistical significance in the model.  For every one unit 
increase in the number of comorbid diseases a participant had, they were approximately 
47% less likely to achieve diastolic blood pressure control, after controlling for all other 
variables in the model.  For every one unit increase in a participant’s age, they were 7% 
more likely to achieve diastolic blood pressure control, after controlling for all other 
variables in the model. 
 
 The results of the logistic regression model with total blood pressure control as the 
dependent variable are shown in Table 4.16.  Adequate hypertension knowledge was not 
significantly associated with total blood pressure control.  The number of comorbid 
diseases was the only predictor variable that exhibited significance in the regression 
model for total blood pressure control.   Every one unit increase in the number of 
comorbid diseases a participant had was associated with being approximately 44% less 
likely to achieve total blood pressure control, after controlling for all other variables in 
the model.  The variable age approached significance as evident by a p-value of 0.051.  
  
 A logistic regression analysis was conducted with Scr within normal limits as the 
dependent variable.  Table 4.17 shows the results of this logistic regression analysis. 
Adequate hypertension knowledge was not significantly associated with having a Scr  
within normal limits.  The variables number of blood pressure medication and number of 
comorbid disease states were significantly associated with having a Scr within normal 
limits.  After controlling for all other variables in the logistic regression model, every one 
unit increase in the number of blood pressure medications was associated with being 55% 
less likely to have a Scr within normal limits.  Every one unit increase in the number of 
comorbid disease states a participant had was associated with being 61% less likely to 
have a Scr within normal limits, after controlling for all other variables in the model.   
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Table 4.14.   Final regression model for systolic blood pressure control  
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Constant -0.815 1.901 0.184 1 0.668 0.443   
Adequate 
HTN 
knowledge (≥ 
70% correct) 
-0.317 0.458 0.481 1 0.488 0.728 0.297 1.786 
LOD 
LOD < 1 
year 
(reference) 
        
LOD 1–5 
years 
1.230 0.699 3.101 1 0.078 3.422 0.870 13.458 
LOD 6–10 
years 
1.764 0.730 5.835 1 0.016 5.837 1.395 24.430 
LOD 11–
15 years 
1.248 0.852 2.143 1 0.143 3.483 0.655 18.510 
LOD 16–
20 years 
0.427 0.948 0.203 1 0.653 1.532 0.239 9.833 
LOD ≥ 20 
years 
0.446 0.808 0.304 1 0.581 1.562 0.320 7.616 
Married 0.105 0.374 0.080 1 0.778 1.111 0.534 2.311 
Monitors salt -0.287 0.394 0.530 1 0.466 0.751 0.347 1.624 
Exercises 0.353 0.337 1.097 1 0.295 1.424 0.735 2.757 
Number of BP 
meds 
-0.238 0.187 1.634 1 0.201 0.788 0.547 1.136 
Number of 
diseases 
-0.566 0.198 8.178 1 0.004 0.568 0.385 0.837 
Age 0.005 0.017 0.091 1 0.763 1.005 0.972 1.040 
Sex 
Female 
(reference) 
        
Male -0.64 0.405 0.025 1 0.874 0.938 0.424 2.075 
Race 
Caucasian 
(reference) 
        
African 
American 
0.002 0.407 0.000 1 0.995 1.002 0.452 2.225 
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Table 4.14.  (continued) 
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Education 
Less than 
HS diploma 
(reference) 
        
HS diploma 
or GED 
-0.155 0.485 0.102 1 0.750 0.857 0.331 2.218 
Greater 
than HS 
diploma 
0.113 0.503 0.050 1 0.822 1.120 0.418 3.001 
Insurance 
Medicare/ 
Other 
(reference) 
        
TennCare 0.774 1,462 0.280 1 0.597 2.168 0.124 38.036 
Medicare 1.247 1.416 0.775 1 0.379 3.479 0.217 55.851 
Private 0.194 1.407 0.019 1 0.890 1.214 0.077 19.118 
Self-pay -0.961 1.794 0.287 1 0.592 0.383 0.011 12.886 
TennCare/ 
Medicare 
0.671 1.487 0.204 1 0.652 1.956 0.106 36.107 
 
n = 196 
Notes:  B indicates logistic regression coefficient; S.E., standard error; Wald, Wald chi-
square statistic; df, degrees of freedom; Sig., significance; HTN, hypertension; LOD, 
length of hypertensive disease; BP meds, blood pressure medications; HS, high school; 
GED, general education diploma. 
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Table 4.15.   Final regression model for diastolic blood pressure control  
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Constant -2.206 1.922 1.317 1 0.251 0.110   
Adequate 
HTN 
knowledge 
(≥70% 
correct) 
-0.398 0.482 0.679 1 0.410 0.672 0.261 1.729 
LOD 
LOD < 1 
year 
(reference) 
        
LOD 1–5 
years 
0.542 0.733 0.546 1 0.460 1.719 0.409 7.230 
LOD 6–10 
years 
-0.106 0.746 0.020 1 0.887 0.900 0.208 3.885 
LOD 11–15 
years 
-0.570 0.874 0.425 1 0.515 0.566 0.102 3.137 
LOD 16–20 
years 
0.945 0.980 0.931 1 0.335 2.573 0.377 17.561 
LOD ≥ 20 
years 
0.248 0.839 0.087 1 0.768 1.281 0.247 6.631 
Married -0.041 0.378 0.012 1 0.914 0.960 0.0460 2.016 
Monitors salt -0.496 0.416 1.424 1 0.233 0.609 0.270 1.375 
Exercises -0.189 0.341 0.308 1 0.579 0.828 0.424 1.615 
Number of BP 
meds 
-0.263 0.187 1.978 1 0.160 0.769 0.533 1.109 
Number of 
diseases 
-0.642 0.201 10.191 1 0.001 0.526 0.355 0.780 
Age 0.069 0.019 13.076 1 < 0.001 1.071 1.032 1.112 
Sex 
Female 
(reference) 
        
Male 0.569 0.408 1.948 1 0.163 1.766 0.795 3.926 
Race 
Caucasian 
(reference) 
        
African 
American 
0.345 0.415 0.689 1 0.407 1.412 0.625 3.186 
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Table 4.15.  (continued) 
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Education 
Less than 
HS diploma 
(reference) 
        
HS diploma 
or GED 
-0.045 0.496 0.008 1 0.928 0.956 0.361 2.529 
Greater 
than HS 
diploma 
0.480 0.523 0.842 1 0.359 1.615 0.580 4.501 
Insurance 
Medicare/ 
Other 
(reference) 
        
TennCare 0.331 1.389 0.057 1 0.812 1.393 0.091 21.202 
Medicare 0.051 1.342 0.001 1 0.970 1.052 0.076 14.592 
Private -0.019 1.327 0.000 1 0.989 0.981 0.073 13.232 
Self-pay 0.325 1.533 0.045 1 0.832 1.384 0.069 27.941 
TennCare/ 
Medicare 
-0.757 1.417 0.285 1 0.593 0.469 0.029 7.543 
 
n = 196 
Notes:  B indicates logistic regression coefficient; S.E., standard error; Wald, Wald chi-
square statistic; df, degrees of freedom; Sig., significance; HTN, hypertension; LOD, 
length of hypertensive disease; BP meds, blood pressure medications; HS, high school; 
GED, general education diploma. 
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Table 4.16.   Final regression model for total blood pressure control 
  
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Constant -2.363 1.909 1.533 1 0.216 0.094   
Adequate 
HTN 
Knowledge 
(≥70% 
correct) 
-0.086 0.474 0.033 1 0.857 0.918 0.363 2.324 
LOD 
LOD < 1 
year 
(reference) 
        
LOD 1–5 
years 
0.513 0.702 0.534 1 0.465 1.670 0.422 6.611 
LOD 6–10 
years 
0.734 0.733 1.005 1 0.316 2.084 0.496 8.759 
LOD 11–15 
years 
-0.014 0.882 0.000 1 0.988 0.986 0.175 5.557 
LOD 16–20 
years 
-0.307 0.996 0.095 1 0.758 0.736 0.104 5.180 
LOD ≥ 20 
years 
-0.217 0.833 0.068 1 0.795 0.805 0.157 4.118 
Married -0.055 0.388 0.020 1 0.888 0.947 0.442 2.026 
Monitors salt -0.269 0.405 0.442 1 0.506 0.764 0.346 1.689 
Exercises 0.140 0.351 0.159 1 0.690 1.150 0.578 2.287 
Number of BP 
meds 
-0.242 0.195 1.544 1 0.214 0.785 0.536 1.150 
Number of 
diseases 
-0.584 0.213 7.547 1 0.006 0.557 0.367 0.846 
Age 0.035 0.018 3.811 1 0.051 1.036 1.000 1.073 
Sex 
Female 
(reference) 
        
Male 0.520 0.436 1.420 1 0.233 1.682 0.715 0.3956 
Race 
Caucasian 
(reference) 
        
African 
American 
0.227 0.430 0.280 1 0.597 1.255 0.541 2.914 
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Table 4.16.  (continued) 
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Education 
Less than 
HS diploma 
(reference) 
        
HS diploma 
or GED 
-0.252 0.506 0.248 1 0.618 0.777 0.288 2.095 
Greater 
than HS 
diploma 
0.171 0.522 0.107 1 0.743 1.187 0.427 3.301 
Insurance 
Medicare/ 
Other 
(reference) 
        
TennCare 0.337 1.411 0.057 1 0.811 1.401 0.088 22.239 
Medicare 0.409 1.353 0.091 1 0.763 1.505 0.106 21.350 
Private 0.223 1.343 0.028 1 0.868 1.250 0.090 17.373 
Self-pay -0.654 1.755 0.139 1 0.709 0.520 0.017 16.216 
TennCare/ 
Medicare 
0.395 1.439 0.075 1 0.784 1.484 0.088 24.903 
 
n = 196 
Notes:  B indicates logistic regression coefficient; S.E., standard error; Wald, Wald chi-
square statistic; df, degrees of freedom; Sig., significance; HTN, hypertension; LOD, 
length of hypertensive disease; BP meds, blood pressure medications; HS, high school; 
GED, general education diploma. 
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Table 4.17.  Final regression model for serum creatinine within normal limits  
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Constant 4.102 3.162 1.683 1 0.195 60.437   
Adequate 
HTN 
Knowledge 
(≥70% 
correct) 
0.968 0.818 1.398 1 0.237 2.632 0.529 13.082 
LOD 
LOD < 1 
year 
(reference) 
        
LOD 1-5 
years 
2.555 1.541 2.749 1 0.097 12.871 0.628 263.853 
LOD 6-10 
years 
1.815 1.455 1.558 1 0.212 6.144 0.355 106.320 
LOD 11-15 
years 
1.469 1.672 0.771 1 0.380 4.344 0.164 115.223 
LOD 16-20 
years 
2.064 1.735 1.415 1 0.234 7.877 0.263 236.026 
LOD ≥ 20 
years 
1.251 1.529 0.669 1 0.413 3.494 0.174 70.001 
Married 0.231 0.741 0.097 1 0.756 1.260 0.295 5.382 
Monitors salt -1.055 0.821 1.651 1 0.199 0.348 0.070 1.740 
Exercises 0.300 0.643 0.218 1 0.641 1.350 0.383 4.760 
Number of BP 
meds 
-0.789 0.285 7.646 1 0.006 0.454 0.260 0.795 
Number of 
diseases 
-0.942 0.367 6.584 1 0.010 0.390 0.190 0.800 
Age 0.007 0.035 0.041 1 0.840 1.007 0.940 1.079 
Sex 
Female 
(reference) 
        
Male 0.454 0.723 0.394 1 0.530 1.575 0.382 6.497 
Race 
Caucasian 
(reference) 
        
African 
American 
-2.494 1.022 5.960 1 0.015 0.083 0.011 0.612 
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Table 4.17.  (continued) 
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Education 
Less than 
HS diploma 
(reference) 
        
HS diploma 
or GED 
-1.607 0.840 3.658 1 0.056 0.200 0.039 1.041 
Greater than 
HS diploma 
0.639 1.059 0.364 1 0.546 1.895 0.238 15.102 
Insurance 
Medicare/ 
Other 
(reference) 
        
TennCare 1.981 2.107 0.884 1 0.347 7.247 0.117 450.564 
Medicare 1.603 1.760 0.829 1 0.362 4.968 0.158 156.468 
Private 1.881 1.898 0.982 1 0.322 6.562 0.159 270.924 
Self-pay 1.051 2.118 0.246 1 0.620 2.860 0.045 181.803 
TennCare/ 
Medicare 
1.467 1.968 0.556 1 0.456 4.337 0.092 205.354 
 
n = 175 
Notes:  B indicates logistic regression coefficient; S.E., standard error; Wald, Wald chi-
square statistic; df, degrees of freedom; Sig., significance; HTN, hypertension; LOD, 
length of hypertensive disease; BP meds, blood pressure medications; HS, high school; 
GED, general education diploma. 
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Additionally, in this model African Americans were 92% less likely to have a Scr within 
normal limits compared to their white counterparts, after controlling for all other 
variables in the model.   
 
Because only 74 participants in the study had a diagnosis of diabetes, the logistic 
regression analysis for HbA1c at goal was conducted using all participants who had a  
HbA1c value available.  Therefore, the analysis was run using 95 participants with the 
knowledge that there may be a lack of power to detect statistical significance.  The results 
for this analysis are shown in Table 4.18.  As with all of the other regression models, 
adequate hypertension knowledge was not significantly associated with having a HbA1c 
at goal.  In this model, race was the only variable that achieved statistical significance.  
African Americans were 74% less likely to have a HbA1c at goal compared to their white 
counterparts. 
 
 Scores on the hypertension knowledge instrument were not a significant predictor of SBP 
control, DBP control, total blood pressure control, Scr within normal limits, or HbA1c at 
goal.  Adequate blood pressure knowledge, defined as a score of 70% or higher on the 
knowledge instrument, was significantly correlated with education.  Individuals with a 
high school diploma or a GED were 3.6 times more likely to have adequate hypertension 
knowledge compared to those with less than a high school diploma or GED.  Also, 
individuals with more than a high school education were 7.6 times more likely to have 
adequate hypertension knowledge compared to those with less than a high school 
diploma or GED (p-value < 0.001).  Additionally, those with private health insurance 
were 12.5 times more likely to have adequate hypertension knowledge compared to those 
with Medicare and a supplemental insurance (p-value = 0.025).  Finally, length of disease 
was significantly correlated with adequate hypertension knowledge.  The odds of 
adequate hypertension knowledge peaked with those who had had a diagnosis of 
hypertension for 11 to 15 years compared to those who had a diagnosis for less than year. 
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Table 4.18.  Final regression model for HbA1c control  
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Constant 0.824 2.794 0.087 1 0.768 2.281   
Adequate 
HTN 
knowledge (≥ 
70% correct) 
-0.711 0.754 0.887 1 0.346 0.491 0.112 2.156 
LOD 
LOD  < 1 
year 
(reference) 
        
LOD 1–5 
years 
1.395 1.435 0.944 1 0.331 4.033 0.242 67.211 
LOD 6–10 
years 
1.379 1.392 0.981 1 0.322 3.970 0.259 60.746 
LOD 11–15 
years 
0.767 1.500 0.262 1 0.609 2.154 0.114 40.710 
LOD 16–20 
years 
-2.614 1.724 2.299 1 0.129 0.073 0.002 2.150 
LOD ≥ 20 
years 
0.547 1.474 0.138 1 0.710 1.728 0.096 31.051 
Married 0.267 0.623 0.183 1 0.668 1.306 0.385 4.424 
Monitors salt -0.429 0.667 0.414 1 0.520 0.651 0.176 2.404 
Exercises -0.066 0.541 0.015 1 0.904 0.937 0.325 2.703 
Number of BP 
Meds 
0.244 0.258 0.891 1 0.345 1.276 0.769 2.117 
Number of 
diseases 
-0.398 0.304 1.712 1 0.191 0.671 0.370 1.219 
Age 0.009 0.030 0.097 1 0.756 1.009 0.952 1.069 
Sex 
Female 
(reference) 
        
Male 0.017 0.674 0.001 1 0.980 1.017 0.272 3.812 
Race 
Caucasian 
(reference) 
        
African 
American 
-1.351 0.631 4.593 1 0.032 0.259 0.075 0.891 
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Table 4.18.  (continued) 
 
Variable B S.E. Wald df Sig. Odds 
Ratio 
95% CI for 
Odds Ratio 
Lower Upper 
Education 
Less than 
HS diploma 
(reference) 
        
HS diploma 
or GED 
-0.943 0.728 1.675 1 0.196 0.390 0.093 1.624 
Greater 
than HS 
diploma 
-0.465 0.846 0.302 1 0.583 0.628 0.120 3.297 
Insurance 
Medicare/ 
Other 
(reference) 
        
TennCare -0.067 1.824 0.001 1 0.971 0.935 0.026 33.356 
Medicare 0.874 1.765 0.245 1 0.620 2.397 0.075 76.227 
Private 0.861 1.713 0.252 1 0.615 2.365 0.082 67.938 
Self-pay -0.792 2.115 0.140 1 0.708 0.453 0.007 28.568 
TennCare/ 
Medicare 
0.572 1.868 0.094 1 0.759 1.772 0.046 69.007 
 
n = 95 
Notes:  B indicates logistic regression coefficient; S.E., standard error; Wald, Wald chi-
square statistic; df, degrees of freedom; Sig., significance; HTN, hypertension; LOD, 
length of hypertensive disease; BP meds, blood pressure medications; HS, high school; 
GED, general education diploma. 
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Chapter 5. Discussion 
 
 
 This chapter is composed of four sections.  The first two sections discuss the results of 
the study and the limitations associated with the study design, respectively.  The third 
section addresses the conclusions that were drawn from the study results.  Finally, 
recommendations for future research are discussed in the fourth section of this chapter. 
 
 
Overview 
 
 The primary purpose of the study was to describe the development and validation of an 
instrument that assesses the knowledge required of patients with hypertension to 
effectively manage their blood pressure.  The secondary purpose of the study was to 
determine the association between hypertension knowledge and outcomes such as 
systolic and diastolic blood pressure and HbA1c.  The Cronbach’s alpha, a measure of 
internal consistency, for the original hypertension knowledge instrument was 0.597 (95% 
CI: 0.505, 0.672).  The Cronbach’s alpha for the refined hypertension knowledge 
instrument was 0.598 (95% CI: 0.504, 0.674).  Although the Cronbach’s alpha did not 
reach the stated cut-off value of 0.70, the achieved Cronbach’s alpha was considered 
acceptable, especially for the first psychometric assessment.  Additionally, the original 
instrument was comprised of only 14 questions and the refined instrument was comprised 
of 9 questions.  Cronbach’s alpha increases as the length of the instrument increases.  The 
study started with a fairly short instrument that was further reduced.  Therefore, the 
length of the instrument prevented the Cronbach’s alpha from increasing much from the 
alpha of the original instrument.  Exploratory factor analysis was used to identify the 
factor structure of the instrument and CFA was used to confirm the structure identified by 
the EFA.  These analyses yielded a three-factor solution: diet, general hypertension 
knowledge, and risk factors and complications of hypertension. 
 
 There was no significant relationship between hypertension knowledge and any of the 
outcomes measured.  Because no significant relationship between hypertension 
knowledge and outcomes was ascertained, the investigator sought to determine what was 
correlated with knowledge.  The variables length of disease, education, and health 
insurance were all independently and significantly correlated with adequate hypertension 
knowledge.   
 
 
Limitations 
 
 From the start of the study, the use of a convenience sample and recall bias with respect 
to past medical history were identified as limitations associated with conducting the 
study.  These limitations were considered acceptable given the study resources.  Past 
medical history was verified with the patient’s medical chart.  However, it is important to 
note that the results of this study can only be generalized to similar clinic settings, which 
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are associated with a teaching medical center and treat mainly low-income minority 
patients. 
 
One of the main limitations of the study was the sample size.  The intended sample size 
of 200 was reduced to 196 due to incomplete data points.  Even though the final sample 
size was not greatly different from 200, this sample size may not have been sufficient to 
detect a relationship between hypertension knowledge and hypertension-related 
outcomes, especially the outcome variable HbA1c at goal for which there was a sample 
size of 95 in the final analysis.  Because there was no effect size in the literature 
regarding the relationship between hypertension knowledge and hypertension-related 
outcomes, the investigator had to assume that the sample size rules for both confirmatory 
and exploratory factor analysis and logistic regression analysis were sufficient to conduct 
the study.  Ideally, the investigator would have liked to collect more than the minimum 
sample size of 200.  However, there were two reasons that prevented the investigator 
from recruiting more than 200 study subjects.  First, as the sample size approached 200 
subjects the investigator began having trouble encountering potential participants who 
had not already participated in the study or had not already declined to participate in the 
study.  Secondly, the investigator was never allowed to conduct the study at the second 
clinic site for which the investigator had IRB approval. 
 
 Another limitation of the study was the inability to incorporate S-TOFHLA scores into 
the regression models.  The investigator speculated that health literacy would mediate the 
relationship between knowledge and outcomes.  However, this relationship could not be 
determined because only 74 out 200 respondents completed the S-TOFHLA.  In order to 
further investigate this phenomenon, the investigator determined whether a relationship 
existed between completion of the S-TOFHLA and level of educational attainment.  
There was no significant relationship between level of educational attainment and 
completion of the S-TOFHLA.  There was also significant response bias as evidenced by 
a mean S-TOFHLA score of approximately 25, indicating adequate health literacy.  
Respondents were asked to complete the S-TOFHLA after answering the hypertension 
knowledge instrument questions.  The majority of the respondents who declined to 
complete the S-TOFHLA simply responded that they did not want to do it.  The S-
TOFHLA measures functional health literacy using the Cloze procedure.  The Cloze 
procedure involves the replacement of every fifth to seventh word in a passage with a 
blank and multiple choices for the correct word.55  Many of the respondents who did 
complete the S-TOFHLA had to read the passages out loud in order to choose an answer.  
Additionally, the way that the S-TOFHLA is printed for administration could have 
influenced whether or not the participant chose to complete the S-TOFHLA.  As the 
respondent reaches the bottom of some of the pages of the S-TOFHLA, the sentences will 
start, but will end at the top of the next page.  Therefore, respondents would have to look 
at the previous page in order to determine the correct answer for the blank on the next 
page.  Based on these observations, the investigator got the impression that many of those 
that declined the S-TOFHLA were intimidated by it. 
 
 A fifth limitation of the study was that 4 of the 14 questions were questions that had “all 
of the above” as an answer option.  The presence of this answer option perhaps decreased 
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the discrimination ability of the instrument.  It is possible that respondents defaulted to 
the “all of the above” answer choice even when they did not know the answer.  It is 
important to note that respondents were instructed not to guess at the answer and if they 
did not know the answer to simply state that they did not know.  These questions are ones 
that need to be re-written in future versions of the instrument to improve reliability. 
 
 Finally, the method of factor analysis has its own limitations.  Currently there is no 
agreed upon sample size.  However, based on the KMO statistic, there was sufficient 
sample size to conduct factor analysis.  Additionally, conducting a factor analysis, 
especially an EFA, requires just as much subjective decision making as objective 
decision making.  Therefore, someone else could potentially make different decisions 
about retaining items and defining factors and have results that are as valid as this study’s 
results. 
 
 
Conclusions 
 
 In summary, the hypertension knowledge instrument is an instrument with acceptable 
validity.  However, as stated four of the instrument items need to be reworded in order to 
remove the “all of the above” answer option and to perhaps increase the discriminating 
power of the items within the instrument.  Although the instrument did not reach the 
Cronbach’s alpha cutoff of 0.70, it is important to not place too much weight on this 
value.  The final structure of the instrument was one that possessed acceptable internal 
consistency and a factor structure that made clinical and theoretical sense. 
 
 This study incorporated various variables of the ITHBC into the regression model in 
order to explain the relationship between hypertension knowledge and hypertension 
outcomes.  However, no significant relationship between these two variables was 
identified.  Demographic variables, race, age, sex and education, were included in the 
model as these are often reported in the literature to influence outcomes.  Age and race 
continue to be important variables with respect to outcomes.  In this study, race was 
found to have a significant relationship with having a Scr within normal limits and having 
a HbA1c at goal.  In both models, African Americans were less likely to be within normal 
limits or at goal.  Age was also found to have a significant relationship with diastolic 
blood pressure control.  However, the demographic variables sex and education were not 
significantly associated with any of the outcome variables.   
 
Although adherence to clinical guidelines and/or hypertensive medications were not 
measured in this study, perhaps more emphasis should be put on these variables and their 
relationship with hypertension outcomes and less emphasis on the demographic variables 
sex and education.  The American Society of Hypertension states that the two gaps that 
must be closed in order to successfully manage hypertension are that of effective research 
and its clinical translation and prescriber recommendations and patient adherence and 
persistence to these recommendations.96  Currently, only 65% of patients with 
hypertension receive drug therapy treatment that is consistent with clinical guidelines.  
Additionally, only 50% of those who receive guideline-relevant treatment persist on their 
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medication for a year.96  If the aforementioned statistics are applied to the current study, 
130 out of 200 patients would have been prescribed medications according to the clinical 
guidelines.  If we take 50% of this now smaller sample, only 65 out of the original 200 
patients would still be taking their medications as indicated after a year of therapy.  
Research has shown that adherence to clinical guidelines by health care providers and 
patient adherence and persistence to medications to treat hypertension results in 
controlled blood pressure and a reduction in macrovascular and microvascular 
complications.  Based on the patient population studied, patients appeared to know or at 
least had been told what they were supposed to do in order to successfully manage their 
high blood pressure.  However, for this study knowledge was not significantly associated 
with blood pressure control.  This finding lends itself to the idea that although 98.5% of 
the study population indicated that they were taking medication for their high blood 
pressure, they instead had been prescribed medications for their high blood pressure but 
was neither adherent nor persistent with their medication use.  Therefore, future studies 
need to include a measure of adherence especially from the standpoint of the patient in 
order to get a clearer picture of the relationship between knowledge and outcomes.  More 
research needs to be done in order to determine why knowledge does not translate into 
improved outcomes.  Is it simply a matter of insufficient sample size or are there 
unmeasured factors that mediate this relationship?  Perhaps these other unmeasured 
factors, such as adherence, are more important predictors of hypertension-related 
outcomes.  The investigator feels that it is a combination of both factors, which can only 
be determined from additional research in the area. 
 
 
Recommendations for Future Research 
 
 The following recommendations for future research stem from the results of this study: 
 
1. Since this study represented the first time the psychometric properties of the 
hypertension knowledge instrument were tested, a follow-up study in a different 
population needs to be conducted in order to further verify the results of this 
study.  Additionally, the four questions that had “all of the above” as an answer 
option should be rewritten so there is only one correct answer from which the 
respondent must choose. 
 
2.  No significant relationship existed between hypertension knowledge and health 
outcomes in this study.  Additional research needs to be performed in order to 
further elucidate the mediating factors between knowledge and outcomes.  The 
influence of variables, such as adherence to clinical treatment guidelines, 
adherence to medications, and self-efficacy with respect to treatment, on the 
relationship between hypertension knowledge and hypertension-related outcomes 
needs to be further investigated.   
 
3.  Additionally, because this study along with other studies cited insufficient sample 
size as a possible reason for not finding a relationship between hypertension 
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knowledge and health outcomes, research needs to be done to determine the effect 
size and thus sample size necessary to detect a difference. 
 
4.  The relationship between current knowledge and the future development of 
complications associated with hypertension has not been established.  Therefore, a 
longitudinal study in which respondent knowledge is assessed at the beginning of 
the study and respondents followed for the development of complications needs to 
be conducted. 
 
5.  The current study investigated adequate hypertension knowledge and 
hypertension-related outcomes with both variables as categorical variables and 
found no significant relationship between knowledge and outcomes.  Future 
studies need to be conducted in order to determine whether a relationship between 
hypertension knowledge and outcomes exists if the variables are measured 
continuously. 
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